VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
BUZDAR, AMAN U
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
AMAN U BUZDAR
Title
Professor
Institution
MD Anderson
Department
Breast Medical Oncology
Address
7007 Bertner Avenue
Houston TX 77054-3403
vCard
Download vCard
Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
Newest
|
Oldest
|
Most Cited
|
Most Discussed
|
Timeline
|
Field Summary
|
Plain Text
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Yam C, Abuhadra N, Sun R,
Adrada BE
, Ding QQ, White JB, Ravenberg EE, Clayborn AR,
Valero V
, Tripathy D,
Damodaran S
,
Arun BK
,
Litton JK
,
Ueno NT
,
Murthy RK
, Lim B, Baez L, Li X,
Buzdar AU
, Hortobagyi GN, Thompson AM,
Mittendorf EA
,
Rauch GM
,
Candelaria RP
,
Huo L
,
Moulder SL
, Chang JT. Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer. Clin Cancer Res. 2022 07 01; 28(13):2878-2889.
PMID:
35507014
; PMCID:
PMC9250637
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Ingle JN, Kalari KR, Barman P, Shepherd LE, Ellis MJ, Goss PE,
Buzdar AU
, Robson ME, Cairns J, Carlson EE, Eyman Casey A, Hoskin TL, Goodnature BA, Haddad TC, Goetz MP, Weinshilboum RM, Wang L. Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer. Pharmacogenet Genomics. 2021 01; 31(1):1-9.
PMID:
32649577
; PMCID:
PMC7655717
.
Citations:
Fields:
Gen
Genetics
Pha
Pharmacology
Translation:
Humans
Cairns J, Ingle JN, Dudenkov TM, Kalari KR, Carlson EE, Na J,
Buzdar AU
, Robson ME, Ellis MJ, Goss PE, Shepherd LE, Goodnature B, Goetz MP, Weinshilboum RM, Li H, Bari MG, Wang L. Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action. JCI Insight. 2020 08 20; 5(16).
PMID:
32701512
; PMCID:
PMC7455128
.
Citations:
6
Fields:
Med
Medicine (General)
Translation:
Humans
CT
Clinical Trials
Dudenkov TM, Liu D, Cairns J, Devarajan S, Zhuang Y, Ingle JN,
Buzdar AU
, Robson ME, Kubo M, Batzler A, Barman P, Jenkins GD, Carlson EE, Goetz MP, Northfelt DW, Moreno-Aspitia A, Desta Z, Reid JM, Kalari KR, Wang L, Weinshilboum RM. Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2. Clin Pharmacol Ther. 2019 07; 106(1):219-227.
PMID:
30648747
; PMCID:
PMC6612579
.
Citations:
3
Fields:
Dru
Drug Therapy
Pha
Pharmacology
Translation:
Humans
Cells
Buzdar AU
, Suman VJ,
Meric-Bernstam F
, Leitch AM, Ellis MJ, Boughey JC, Unzeitig GW, Royce ME,
Hunt KK
. Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial. JAMA Oncol. 2019 01 01; 5(1):45-50.
PMID:
30193295
; PMCID:
PMC6331049
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Yam C,
Murthy RK
,
Valero V
,
Szklaruk J
,
Shroff GS
, Stalzer CJ,
Buzdar AU
, Murray JL, Yang W, Hortobagyi GN,
Moulder SL
,
Arun B
. A phase II study of tipifarnib and gemcitabine in metastatic breast cancer. Invest New Drugs. 2018 04; 36(2):299-306.
PMID:
29374384
.
Citations:
5
Fields:
Ant
Antineoplastic Agents
Pha
Pharmacology
Translation:
Humans
CT
Clinical Trials
Lesurf R, Griffith OL, Griffith M, Hundal J, Trani L, Watson MA, Aft R, Ellis MJ, Ota D, Suman VJ,
Meric-Bernstam F
, Leitch AM, Boughey JC, Unzeitig G,
Buzdar AU
, Hunt KK, Mardis ER. Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial. Ann Oncol. 2017 05 01; 28(5):1070-1077.
PMID:
28453704
; PMCID:
PMC5790063
.
Citations:
29
Fields:
Neo
Neoplasms
Translation:
Humans
Dudenkov TM, Ingle JN,
Buzdar AU
, Robson ME, Kubo M, Ibrahim-Zada I, Batzler A, Jenkins GD, Pietrzak TL, Carlson EE, Barman P, Goetz MP, Northfelt DW, Moreno-Aspita A, Williard CV, Kalari KR, Nakamura Y, Wang L, Weinshilboum RM. SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+?breast cancer: genome-wide association studies of the estrone pathway. Breast Cancer Res Treat. 2017 Jul; 164(1):189-199.
PMID:
28429243
; PMCID:
PMC5600471
.
Citations:
12
Fields:
Neo
Neoplasms
Translation:
Humans
Tang C,
Sherman SI
, Price M, Weng J, Davis SE,
Hong DS
,
Yao JC
,
Buzdar A
,
Wilding G
,
Lee JJ
. Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement. Clin Cancer Res. 2017 Mar 15; 23(6):1414-1421.
PMID:
28275168
; PMCID:
PMC5354950
.
Citations:
13
Fields:
Neo
Neoplasms
Translation:
Humans
Symmans WF
, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A,
Ramineni M
, Sinn B,
Hunt K
,
Buchholz TA
,
Valero V
,
Buzdar AU
, Yang W,
Brewster AM
,
Moulder S
, Pusztai L, Hatzis C, Hortobagyi GN. Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype. J Clin Oncol. 2017 Apr 01; 35(10):1049-1060.
PMID:
28135148
; PMCID:
PMC5455352
.
Citations:
161
Fields:
Neo
Neoplasms
Translation:
Humans
Freedman RA, Seisler DK, Foster JC, Sloan JA, Lafky JM, Kimmick GG, Hurria A, Cohen HJ, Winer EP, Hudis CA, Partridge AH, Carey LA, Jatoi A, Klepin HD, Citron M,
Berry DA
, Shulman LN,
Buzdar AU
, Suman VJ, Muss HB. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Breast Cancer Res Treat. 2017 01; 161(2):363-373.
PMID:
27866278
; PMCID:
PMC5226883
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Tang C,
Hess KR
, Sanders D, Davis SE,
Buzdar AU
, Kurzrock R, Lee JJ,
Meric-Bernstam F
,
Hong DS
. Modifying the Clinical Research Infrastructure at a Dedicated Clinical Trials Unit: Assessment of Trial Development, Activation, and Participant Accrual. Clin Cancer Res. 2017 Mar 15; 23(6):1407-1413.
PMID:
27852698
; PMCID:
PMC5872813
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Warner ET, Ballman KV, Strand C, Boughey JC,
Buzdar AU
, Carey LA, Sikov WM, Partridge AH. Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426). Breast Cancer Res Treat. 2016 08; 159(1):109-18.
PMID:
27449492
; PMCID:
PMC5011019
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F,
Buzdar AU
, Fumoleau P, Gradishar W, Moy B, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE, Martin M, Piccart-Gebhart M. Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. Eur J Cancer. 2016 Mar; 56:85-92.
PMID:
26829011
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Dowsett M, Sestak I, Buus R, Lopez-Knowles E, Mallon E, Howell A, Forbes JF,
Buzdar A
, Cuzick J. Estrogen Receptor Expression in 21-Gene Recurrence Score Predicts Increased Late Recurrence for Estrogen-Positive/HER2-Negative Breast Cancer. Clin Cancer Res. 2015 Jun 15; 21(12):2763-70.
PMID:
26078431
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F,
Buzdar AU
, Fumoleau P, Gradishar W, Moy B, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE, Martin M, Piccart-Gebhart M. Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy. Breast Cancer Res. 2015 Apr 16; 17:56.
PMID:
25888246
; PMCID:
PMC4423419
.
Citations:
16
Fields:
Neo
Neoplasms
Translation:
Humans
Boyle FM, Smith IE, O'Shaughnessy J, Ejlertsen B,
Buzdar AU
, Fumoleau P, Gradishar W, Moy B, Pritchard KI, Lindquist D, Amonkar M, Huang Y, Rappold E, Williams LS, Wang-Silvanto J, Kaneko T, Finkelstein DM, Goss PE, TEACH Investigators, Martin M, Piccart-Gebhart M. Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer. Eur J Cancer. 2015 Apr; 51(6):685-96.
PMID:
25752740
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Ingle JN, Kalari KR,
Buzdar AU
, Robson ME, Goetz MP, Desta Z, Barman P, Dudenkov TT, Northfelt DW, Perez EA, Flockhart DA, Williard CV, Wang L, Weinshilboum RM. Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole. Steroids. 2015 Jul; 99(Pt A):32-8.
PMID:
25163006
; PMCID:
PMC4339673
.
Citations:
18
Fields:
Bio
Biochemistry
Translation:
Humans
CT
Clinical Trials
McBride A, Allen P,
Woodward W
, Kim M,
Kuerer HM
, Drinka EK,
Sahin A
,
Strom EA
,
Buzdar A
,
Valero V
, Hortobagyi GN,
Hunt KK
,
Buchholz TA
. Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol Biol Phys. 2014 Jun 01; 89(2):392-8.
PMID:
24721590
.
Citations:
38
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
Yi M,
Huo L
,
Koenig KB
, Mittendorf EA,
Meric-Bernstam F
,
Kuerer HM
,
Bedrosian I
,
Buzdar AU
,
Symmans WF
, Crow JR, Bender M, Shah RR, Hortobagyi GN,
Hunt KK
. Which threshold for ER positivity? a retrospective study based on 9639 patients. Ann Oncol. 2014 May; 25(5):1004-11.
PMID:
24562447
; PMCID:
PMC3999801
.
Citations:
62
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Suman VJ,
Meric-Bernstam F
, Leitch AM, Ellis MJ, Boughey JC, Unzeitig G, Royce M, McCall LM, Ewer MS,
Hunt KK
, American College of Surgeons Oncology Group investigators. Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial. Lancet Oncol. 2013 Dec; 14(13):1317-25.
PMID:
24239210
; PMCID:
PMC4176878
.
Citations:
61
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. Meta-analysis: selective estrogen-receptor modulators reduce breast cancer incidence. Ann Intern Med. 2013 Sep 17; 159(6):JC9.
PMID:
24042392
.
Citations:
Fields:
Int
Internal Medicine
Translation:
Humans
Buzdar AU
. Combination endocrine treatments unproven in breast cancer. Lancet Oncol. 2013 Sep; 14(10):917-8.
PMID:
23902873
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Afentakis M, Dowsett M, Sestak I, Salter J, Howell T,
Buzdar A
, Forbes J, Cuzick J. Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study. Breast Cancer Res Treat. 2013 Jul; 140(2):253-62.
PMID:
23852223
.
Citations:
9
Fields:
Neo
Neoplasms
Translation:
Humans
Litton J
,
Buzdar A
, Mac Gregor MC, Gonzalez-Angulo A, Hortobagyi G. Tamoxifen therapy for patients with breast cancer. Lancet. 2013 Jun 15; 381(9883):2077-8.
PMID:
23769223
.
Citations:
1
Fields:
Med
Medicine (General)
Translation:
Humans
Kelly CM,
Buzdar AU
. Using multiple targeted therapies in oncology: considerations for use, and progress to date in breast cancer. Drugs. 2013 May; 73(6):505-15.
PMID:
23605692
.
Citations:
7
Fields:
Dru
Drug Therapy
Pha
Pharmacology
Translation:
Humans
Animals
Kim MM, Allen P, Gonzalez-Angulo AM, Woodward WA,
Meric-Bernstam F
,
Buzdar AU
,
Hunt KK
,
Kuerer HM
, Litton JK, Hortobagyi GN,
Buchholz TA
, Mittendorf EA. Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer. Ann Oncol. 2013 Aug; 24(8):1999-2004.
PMID:
23562929
; PMCID:
PMC3718505
.
Citations:
22
Fields:
Neo
Neoplasms
Translation:
Humans
Liu M, Ingle JN, Fridley BL,
Buzdar AU
, Robson ME, Kubo M, Wang L, Batzler A, Jenkins GD, Pietrzak TL, Carlson EE, Goetz MP, Northfelt DW, Perez EA, Williard CV, Schaid DJ, Nakamura Y, Weinshilboum RM. TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression. Mol Endocrinol. 2013 Apr; 27(4):657-70.
PMID:
23518928
; PMCID:
PMC3607698
.
Citations:
29
Fields:
End
Endocrinology
Mol
Molecular Biology
Translation:
Humans
Cells
CT
Clinical Trials
Vachon CM, Suman VJ, Brandt KR, Kosel ML,
Buzdar AU
, Olson JE, Wu FF, Flickinger LM, Ursin G, Elliott CR, Shepherd L, Weinshilboum RM, Goss PE, Ingle JN. Mammographic breast density response to aromatase inhibition. Clin Cancer Res. 2013 Apr 15; 19(8):2144-53.
PMID:
23468058
; PMCID:
PMC3630282
.
Citations:
17
Fields:
Neo
Neoplasms
Translation:
Humans
Goss PE, Smith IE, O'Shaughnessy J, Ejlertsen B, Kaufmann M, Boyle F,
Buzdar AU
, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Chavarri-Guerra Y, Aktan G, Rappold E, Williams LS, Finkelstein DM, TEACH investigators. Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial. Lancet Oncol. 2013 Jan; 14(1):88-96.
PMID:
23234763
.
Citations:
44
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Lyman GH, Burstein HJ,
Buzdar AU
, D'Agostino R, Ellis PA. Making genuine progress against metastatic breast cancer. J Clin Oncol. 2012 Oct 01; 30(28):3448-51.
PMID:
22927527
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Kelly CM, Green MC, Broglio K, Thomas ES,
Brewster AM
,
Valero V
,
Ibrahim NK
, Gonzalez-Angulo AM,
Booser DJ
,
Walters RS
,
Hunt KK
, Hortobagyi GN,
Buzdar AU
. Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer. J Clin Oncol. 2012 Mar 20; 30(9):930-5.
PMID:
22331946
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Barrios C, Forbes JF, Jonat W, Conte P, Gradishar W,
Buzdar A
, Gelmon K, Gnant M, Bonneterre J, Toi M, Hudis C, Robertson JF. The sequential use of endocrine treatment for advanced breast cancer: where are we? Ann Oncol. 2012 Jun; 23(6):1378-86.
PMID:
22317766
; PMCID:
PMC6267865
.
Citations:
22
Fields:
Neo
Neoplasms
Translation:
Humans
Kelly CM,
Buzdar AU
. Aromatase inhibitors in premenopausal breast cancer. Lancet Oncol. 2012 Apr; 13(4):320-1.
PMID:
22265695
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Ewer MS, Yang M,
Buzdar AU
. Screening for cardiac risk before anthracycline administration: what are the real benefits? Clin Breast Cancer. 2012 Feb; 12(1):1-3.
PMID:
22130035
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Arun B
,
Valero V
, Liu D,
Brewster A
, Green M, Gutierrez-Barrera A, Akar U, Rivera E, Esteva FJ,
Buzdar AU
, Hortobagyi GN, Sneige N. Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer. Cancer Prev Res (Phila). 2012 Feb; 5(2):276-82.
PMID:
22102688
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Yi M,
Mittendorf EA
,
Cormier JN
,
Buchholz TA
, Bilimoria K,
Sahin AA
, Hortobagyi GN, Gonzalez-Angulo AM, Luo S,
Buzdar AU
, Crow JR,
Kuerer HM
,
Hunt KK
. Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. J Clin Oncol. 2011 Dec 10; 29(35):4654-61.
PMID:
22084362
; PMCID:
PMC3236648
.
Citations:
33
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar A
, Vogel C, Schwartzberg L, Garin A, Perez A, Ingle J, Houghton M, Zergebel C, Kimball B. Randomized double-blind phase 2 trial of 3 doses of TAS-108 in patients with advanced or metastatic postmenopausal breast cancer. Cancer. 2012 Jul 01; 118(13):3244-53.
PMID:
22045595
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Spinks T, Albright HW,
Feeley TW
,
Walters R
,
Burke TW
,
Aloia T
,
Bruera E
,
Buzdar A
,
Foxhall L
,
Hui D
, Summers B,
Rodriguez A
, Dubois R, Shine KI. Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer. 2012 May 15; 118(10):2571-82.
PMID:
22045610
; PMCID:
PMC3272132
.
Citations:
23
Fields:
Neo
Neoplasms
Translation:
Humans
Arun BK
, Dhinghra K,
Valero V
, Kau SW, Broglio K,
Booser D
, Guerra L, Yin G,
Walters R
,
Sahin A
,
Ibrahim N
,
Buzdar AU
, Frye D, Sneige N,
Strom E
,
Ross M
, Theriault RL, Vadhan-Raj S, Hortobagyi GN. Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results. Oncologist. 2011; 16(11):1527-34.
PMID:
22042783
; PMCID:
PMC3233286
.
Citations:
10
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Ring A, Sestak I, Baum M, Howell A,
Buzdar A
, Dowsett M, Forbes JF, Cuzick J. Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial. J Clin Oncol. 2011 Nov 10; 29(32):4266-72.
PMID:
21990403
.
Citations:
17
Fields:
Neo
Neoplasms
Translation:
Humans
Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, Zabaglo L, Mallon E, Green AR, Ellis IO, Howell A,
Buzdar AU
, Forbes JF. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol. 2011 Nov 10; 29(32):4273-8.
PMID:
21990413
.
Citations:
251
Fields:
Neo
Neoplasms
Translation:
Humans
Jung EJ, Santarpia L, Kim J, Esteva FJ, Moretti E,
Buzdar AU
, Di Leo A, Le XF, Bast RC, Park ST, Pusztai L,
Calin GA
. Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer. 2012 May 15; 118(10):2603-14.
PMID:
22370716
; PMCID:
PMC3864019
.
Citations:
117
Fields:
Neo
Neoplasms
Translation:
Humans
Bayraktar S, Gonzalez-Angulo AM, Lei X,
Buzdar AU
,
Valero V
, Melhem-Bertrandt A,
Kuerer HM
, Hortobagyi GN,
Sahin AA
,
Meric-Bernstam F
. Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer. Cancer. 2012 May 01; 118(9):2385-93.
PMID:
21953213
; PMCID:
PMC3274632
.
Citations:
21
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Xu B, Digumarti R, Goedhals L, Hu X, Semiglazov V, Cheporov S, Gotovkin E, Rittweger K, Miles DW, O'Shaughnessy J, Tjulandin S, NO16853 trial group, Hoersch S. Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer. Ann Oncol. 2012 Mar; 23(3):589-597.
PMID:
21633047
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Albert JM,
Buzdar AU
, Guzman R, Allen PK,
Strom EA
,
Perkins GH
,
Woodward WA
,
Hoffman KE
,
Tereffe W
,
Hunt KK
,
Buchholz TA
, Oh JL. Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control. Breast Cancer Res Treat. 2011 Jul; 128(2):421-7.
PMID:
21553292
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Mittendorf EA
, Jeruss JS, Tucker SL, Kolli A, Newman LA, Gonzalez-Angulo AM,
Buchholz TA
,
Sahin AA
,
Cormier JN
,
Buzdar AU
, Hortobagyi GN,
Hunt KK
. Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol. 2011 May 20; 29(15):1956-62.
PMID:
21482989
; PMCID:
PMC3107758
.
Citations:
35
Fields:
Neo
Neoplasms
Translation:
Humans
Dowsett M, Salter J, Zabaglo L, Mallon E, Howell A,
Buzdar AU
, Forbes J, Pineda S, Cuzick J. Predictive algorithms for adjuvant therapy: TransATAC. Steroids. 2011 Jul; 76(8):777-80.
PMID:
21470560
.
Citations:
9
Fields:
Bio
Biochemistry
Translation:
Humans
Buzdar AU
. Anti-angiogenic therapies in metastatic breast cancer-an unfulfilled dream. Lancet Oncol. 2011 Apr; 12(4):316-8.
PMID:
21429798
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Yi M,
Buchholz TA
,
Meric-Bernstam F
,
Bedrosian I
,
Hwang RF
,
Ross MI
,
Kuerer HM
, Luo S, Gonzalez-Angulo AM,
Buzdar AU
,
Symmans WF
,
Feig BW
,
Lucci A
, Huang EH,
Hunt KK
. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg. 2011 Mar; 253(3):572-9.
PMID:
21209588
; PMCID:
PMC4331097
.
Citations:
13
Fields:
Gen
General Surgery
Translation:
Humans
Ferrajoli A
,
Buzdar AU
, Dejesus Y, Cheng L, Michaud LB,
Rodriguez MA
. Usage of erythropoiesis-stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia. Cancer. 2011 Jul 15; 117(14):3268-75.
PMID:
21264831
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Cuzick J, Sestak I, Baum M,
Buzdar A
, Howell A, Dowsett M, Forbes JF, ATAC/LATTE investigators. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol. 2010 Dec; 11(12):1135-41.
PMID:
21087898
.
Citations:
294
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Kelly CM,
Buzdar AU
. Anastrozole. Expert Opin Drug Saf. 2010 Nov; 9(6):995-1003.
PMID:
20923259
.
Citations:
7
Fields:
Dru
Drug Therapy
Pha
Pharmacology
Translation:
Humans
Mazouni C,
Baggerly K
, Hawke D, Tsavachidis S,
Buzdar AU
, Martin PM, Kobayashi R, Pusztai L, Andr? F. Evaluation of changes in serum protein profiles during neoadjuvant chemotherapy in HER2-positive breast cancer using an LC-MALDI-TOF/MS procedure. Proteomics. 2010 Oct; 10(19):3525-32.
PMID:
20827732
.
Citations:
7
Fields:
Bio
Biochemistry
Translation:
Humans
Kuerer HM
,
Buzdar AU
,
Mittendorf EA
, Esteva FJ,
Lucci A
, Vence LM, Radvanyi L,
Meric-Bernstam F
,
Hunt KK
,
Symmans WF
. Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast. Cancer. 2011 Jan 01; 117(1):39-47.
PMID:
20740500
; PMCID:
PMC2997136
.
Citations:
26
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Wefel JS
, Saleeba AK,
Buzdar AU
, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010 Jul 15; 116(14):3348-56.
PMID:
20564075
.
Citations:
166
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Dominici LS, Negron Gonzalez VM,
Buzdar AU
,
Lucci A
,
Mittendorf EA
,
Le-Petross HT
,
Babiera GV
,
Meric-Bernstam F
,
Hunt KK
,
Kuerer HM
. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer. 2010 Jun 15; 116(12):2884-9.
PMID:
20564395
; PMCID:
PMC4361091
.
Citations:
44
Fields:
Neo
Neoplasms
Translation:
Humans
Ingle JN,
Buzdar AU
, Schaid DJ, Goetz MP, Batzler A, Robson ME, Northfelt DW, Olson JE, Perez EA, Desta Z, Weintraub RA, Williard CV, Flockhart DA, Weinshilboum RM. Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer. Cancer Res. 2010 Apr 15; 70(8):3278-86.
PMID:
20354183
; PMCID:
PMC2855746
.
Citations:
28
Fields:
Neo
Neoplasms
Translation:
Humans
Dowsett M, Cuzick J, Wale C, Forbes J, Mallon EA, Salter J, Quinn E, Dunbier A, Baum M,
Buzdar A
, Howell A, Bugarini R, Baehner FL, Shak S. Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study. J Clin Oncol. 2010 Apr 10; 28(11):1829-34.
PMID:
20212256
.
Citations:
258
Fields:
Neo
Neoplasms
Translation:
Humans
Moulder SL
, Holmes FA, Tolcher AW,
Thall P
, Broglio K, Valero V,
Buzdar AU
, Arbuck SG, Seidman A, Hortobagyi GN. A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer. Cancer. 2010 Feb 15; 116(4):814-21.
PMID:
20052721
; PMCID:
PMC3806193
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
Kelly CM,
Buzdar AU
. Aromatase inhibitors alone or in sequence with tamoxifen - clinical evaluation of the BIG 1-98 trial. Expert Opin Pharmacother. 2010 Feb; 11(3):489-92.
PMID:
20053139
.
Citations:
2
Fields:
Pha
Pharmacology
Translation:
CT
Clinical Trials
Buzdar AU
, Quinaux E, Jacobs S, Rastogi P, Fourchotte V, Younan RJ, Pajon ER, Shalaby IA, Desai AM, Fehrenbacher L, Geyer CE, Mamounas EP, Wolmark N, Robidoux A. A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer. Clin Breast Cancer. 2010 Feb; 10(1):81-6.
PMID:
20133263
.
Citations:
22
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Wang L, Ellsworth KA, Moon I, Pelleymounter LL, Eckloff BW, Martin YN, Fridley BL, Jenkins GD, Batzler A, Suman VJ, Ravi S, Dixon JM, Miller WR, Wieben ED,
Buzdar A
, Weinshilboum RM, Ingle JN. Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors. Cancer Res. 2010 Jan 01; 70(1):319-28.
PMID:
20048079
; PMCID:
PMC2804935
.
Citations:
43
Fields:
Neo
Neoplasms
Translation:
Humans
Jones KL,
Buzdar AU
. Evolving novel anti-HER2 strategies. Lancet Oncol. 2009 Dec; 10(12):1179-87.
PMID:
19959074
.
Citations:
40
Fields:
Neo
Neoplasms
Translation:
Humans
Animals
Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M,
Buzdar A
, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godwin J, Davies C, Peto R. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol. 2010 Jan 20; 28(3):509-18.
PMID:
19949017
.
Citations:
260
Fields:
Neo
Neoplasms
Translation:
Humans
Dawood S, Broglio K,
Buzdar AU
, Hortobagyi GN,
Giordano SH
. Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. J Clin Oncol. 2010 Jan 01; 28(1):92-8.
PMID:
19933921
; PMCID:
PMC2799236
.
Citations:
259
Fields:
Neo
Neoplasms
Translation:
Humans
Mittendorf EA
, Wu Y, Scaltriti M,
Meric-Bernstam F
,
Hunt KK
, Dawood S, Esteva FJ,
Buzdar AU
, Chen H, Eksambi S, Hortobagyi GN, Baselga J, Gonzalez-Angulo AM. Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes. Clin Cancer Res. 2009 Dec 01; 15(23):7381-8.
PMID:
19920100
; PMCID:
PMC2788123
.
Citations:
121
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Reyes-Gibby CC
, Morrow PK,
Buzdar A
,
Shete S
. Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel. J Pain. 2009 Nov; 10(11):1146-50.
PMID:
19595634
; PMCID:
PMC2783933
.
Citations:
36
Fields:
Neu
Neurology
Psy
Psychophysiology
Translation:
Humans
Chlebowski R, Cuzick J, Amakye D, Bauerfeind I,
Buzdar A
, Chia S, Cutuli B, Linforth R, Noguchi S, Verma S, Hadji P, Maass N, Robidoux A. Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer. Breast. 2009 Aug; 18 Suppl 2:S1-11.
PMID:
19712865
.
Citations:
15
Fields:
End
Endocrinology
Neo
Neoplasms
Translation:
Humans
PH
Public Health
Buzdar AU
. Medical oncology: Endocrine-therapy-related symptoms and breast cancer. Nat Rev Clin Oncol. 2009 Jun; 6(6):309-10.
PMID:
19483735
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer. Ann Oncol. 2009 Jun; 20(6):993-9.
PMID:
19150946
.
Citations:
30
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Gonzalez-Angulo AM,
Walters R
, Broglio K, Frye DK,
Strom EA
, Theriault RL,
Booser DJ
, Valero V,
Buzdar AU
, Hortobagyi GN. Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancer. Clin Breast Cancer. 2008 Dec; 8(6):516-21.
PMID:
19073507
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer. Drugs Today (Barc). 2008 Sep; 44(9):679-92.
PMID:
19137123
.
Citations:
5
Fields:
Dru
Drug Therapy
Translation:
Humans
Litton JK
, Gonzalez-Angulo AM, Warneke CL,
Buzdar AU
, Kau SW, Bondy M, Mahabir S, Hortobagyi GN,
Brewster AM
. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol. 2008 Sep 01; 26(25):4072-7.
PMID:
18757321
; PMCID:
PMC6557586
.
Citations:
71
Fields:
Neo
Neoplasms
Translation:
Humans
Dawood S, Broglio K, Gonzalez-Angulo AM,
Buzdar AU
, Hortobagyi GN,
Giordano SH
. Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol. 2008 Oct 20; 26(30):4891-8.
PMID:
18725649
; PMCID:
PMC2736998
.
Citations:
76
Fields:
Neo
Neoplasms
Translation:
Humans
Jeruss JS,
Mittendorf EA
, Tucker SL, Gonzalez-Angulo AM,
Buchholz TA
,
Sahin AA
,
Cormier JN
,
Buzdar AU
, Hortobagyi GN,
Hunt KK
. Staging of breast cancer in the neoadjuvant setting. Cancer Res. 2008 Aug 15; 68(16):6477-81.
PMID:
18701468
; PMCID:
PMC4441792
.
Citations:
12
Fields:
Neo
Neoplasms
Translation:
Humans
Sestak I, Cuzick J, Sapunar F, Eastell R, Forbes JF, Bianco AR,
Buzdar AU
, ATAC Trialists' Group. Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis. Lancet Oncol. 2008 Sep; 9(9):866-72.
PMID:
18703382
.
Citations:
66
Fields:
Neo
Neoplasms
Translation:
Humans
Brewster AM
, Hortobagyi GN, Broglio KR, Kau SW, Santa-Maria CA,
Arun B
,
Buzdar AU
,
Booser DJ
,
Valero V
, Bondy M, Esteva FJ. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst. 2008 Aug 20; 100(16):1179-83.
PMID:
18695137
; PMCID:
PMC6592411
.
Citations:
148
Fields:
Neo
Neoplasms
Translation:
Humans
Jackson LR, Cheung KL,
Buzdar AU
, Robertson JF. Arzoxifene: the evidence for its development in the management of breast cancer. Core Evid. 2008 Jul 31; 2(4):251-8.
PMID:
21221190
; PMCID:
PMC3012444
.
Citations:
2
Peintinger F,
Buzdar AU
,
Kuerer HM
, Mejia JA, Hatzis C, Gonzalez-Angulo AM, Pusztai L, Esteva FJ, Dawood SS, Green MC, Hortobagyi GN,
Symmans WF
. Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab. Ann Oncol. 2008 Dec; 19(12):2020-5.
PMID:
18667396
; PMCID:
PMC2733116
.
Citations:
13
Fields:
Neo
Neoplasms
Translation:
Humans
Eralp Y, Smith TL, Altundag K, Kau SW,
Litton J
,
Valero V
,
Buzdar A
, Hortobagyi GN,
Arun B
. Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger. J Cancer Res Clin Oncol. 2009 Jan; 135(1):141-8.
PMID:
18581139
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Mazouni C,
Arun B
, Ayers M,
Krishnamurthy S
, Wang B, Hortobagyi GN,
Buzdar AU
, Pusztai L, Andr? F. Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers. Br J Cancer. 2008 Jul 08; 99(1):68-71.
PMID:
18560403
; PMCID:
PMC2453019
.
Citations:
13
Fields:
Neo
Neoplasms
Translation:
Humans
Chia S, Gradishar W, Mauriac L, Bines J, Amant F, Federico M, Fein L, Romieu G,
Buzdar A
, Robertson JF, Brufsky A, Possinger K, Rennie P, Sapunar F, Lowe E, Piccart M. Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT. J Clin Oncol. 2008 Apr 01; 26(10):1664-70.
PMID:
18316794
.
Citations:
142
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. Clinical experience with epothilones in patients with breast cancer. Clin Breast Cancer. 2008 Mar; 8 Suppl 2:S71-8.
PMID:
18637402
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Gralow JR, Burstein HJ, Wood W, Hortobagyi GN, Gianni L, von Minckwitz G,
Buzdar AU
, Smith IE,
Symmans WF
, Singh B, Winer EP. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease. J Clin Oncol. 2008 Feb 10; 26(5):814-9.
PMID:
18258991
.
Citations:
123
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Coombes RC, Goss PE, Winer EP. Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer. Cancer. 2008 Feb 01; 112(3 Suppl):700-709.
PMID:
18072256
.
Citations:
16
Fields:
Neo
Neoplasms
Translation:
Humans
Come SE,
Buzdar AU
, Ingle JN, Johnston SRD, Brodie AM, Coombes RC, Miller WR, Pritchard KI, Winer EP, Zujewski JA, Goss PE. Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference. Cancer. 2008 Feb 01; 112(3 Suppl):673-678.
PMID:
18072254
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Dowsett M, Allred C, Knox J, Quinn E, Salter J, Wale C, Cuzick J, Houghton J, Williams N, Mallon E, Bishop H, Ellis I, Larsimont D, Sasano H, Carder P, Cussac AL, Knox F, Speirs V, Forbes J,
Buzdar A
. Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial. J Clin Oncol. 2008 Mar 01; 26(7):1059-65.
PMID:
18227529
.
Citations:
132
Fields:
Neo
Neoplasms
Translation:
Humans
Boughey JC,
Buzdar AU
,
Hunt KK
. Recent advances in the hormonal treatment of breast cancer. Curr Probl Surg. 2008 Jan; 45(1):13-55.
PMID:
18206436
.
Citations:
Fields:
Gen
General Surgery
Translation:
Humans
Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, Forbes JF, Cuzick J,
Buzdar A
, Howell A, Tobias JS, Baum M. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 2008 Jan; 9(1):45-53.
PMID:
18083636
.
Citations:
310
Fields:
Neo
Neoplasms
Translation:
Humans
Jeruss JS,
Mittendorf EA
, Tucker SL, Gonzalez-Angulo AM,
Buchholz TA
,
Sahin AA
,
Cormier JN
,
Buzdar AU
, Hortobagyi GN,
Hunt KK
. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol. 2008 Jan 10; 26(2):246-52.
PMID:
18056680
.
Citations:
49
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Preoperative chemotherapy treatment of breast cancer--a review. Cancer. 2007 Dec 01; 110(11):2394-407.
PMID:
17941030
.
Citations:
24
Fields:
Neo
Neoplasms
Translation:
Humans
Kaufmann M, von Minckwitz G, Bear HD,
Buzdar A
, McGale P, Bonnefoi H, Colleoni M, Denkert C, Eiermann W, Jackesz R, Makris A, Miller W, Pierga JY, Semiglazov V, Schneeweiss A, Souchon R, Stearns V, Untch M, Loibl S. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol. 2007 Dec; 18(12):1927-34.
PMID:
17998286
.
Citations:
103
Fields:
Neo
Neoplasms
Translation:
Humans
Deshmane V,
Krishnamurthy S
, Melemed AS, Peterson P,
Buzdar AU
. Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer. J Clin Oncol. 2007 Nov 01; 25(31):4967-73.
PMID:
17971595
.
Citations:
21
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Cristofanilli M, Valero V,
Buzdar AU
, Kau SW, Broglio KR, Gonzalez-Angulo AM, Sneige N, Islam R,
Ueno NT
,
Buchholz TA
, Singletary SE, Hortobagyi GN. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease. Cancer. 2007 Oct 01; 110(7):1436-44.
PMID:
17694554
.
Citations:
69
Fields:
Neo
Neoplasms
Translation:
Humans
Dawood S, Gonzalez-Angulo AM, Peintinger F, Broglio K,
Symmans WF
, Kau SW, Islam R, Hortobagyi GN,
Buzdar AU
. Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience. Cancer. 2007 Sep 15; 110(6):1195-200.
PMID:
17647266
.
Citations:
12
Fields:
Neo
Neoplasms
Translation:
Humans
Symmans WF
, Peintinger F, Hatzis C, Rajan R,
Kuerer H
, Valero V, Assad L, Poniecka A, Hennessy B, Green M,
Buzdar AU
, Singletary SE, Hortobagyi GN, Pusztai L. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007 Oct 01; 25(28):4414-22.
PMID:
17785706
.
Citations:
450
Fields:
Neo
Neoplasms
Translation:
Humans
Gonzalez-Angulo AM, Hennessy BT, Broglio K,
Meric-Bernstam F
, Cristofanilli M,
Giordano SH
,
Buchholz TA
,
Sahin A
, Singletary SE,
Buzdar AU
, Hortob?gyi GN. Trends for inflammatory breast cancer: is survival improving? Oncologist. 2007 Aug; 12(8):904-12.
PMID:
17766649
.
Citations:
48
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer. J Clin Oncol. 2007 May 20; 25(15):2147-8; author reply 2148.
PMID:
17513830
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Adjuvant chemotherapy for high-risk operable breast cancer. J Clin Oncol. 2007 May 01; 25(13):1642-4.
PMID:
17404366
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Mazouni C, Kau SW, Frye D, Andre F,
Kuerer HM
,
Buchholz TA
,
Symmans WF
, Anderson K, Hess KR, Gonzalez-Angulo AM, Hortobagyi GN,
Buzdar AU
, Pusztai L. Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers. Ann Oncol. 2007 May; 18(5):874-80.
PMID:
17293601
.
Citations:
20
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Mazouni C, Hall A, Broglio K, Fritsche H, Andre F, Esteva FJ, Hortobagyi GN,
Buzdar AU
, Pusztai L, Cristofanilli M. Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy. Cancer. 2007 Feb 01; 109(3):496-501.
PMID:
17149760
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
Esteva FJ,
Wang J
, Lin F, Mejia JA, Yan K, Altundag K, Valero V,
Buzdar AU
, Hortobagyi GN,
Symmans WF
, Pusztai L. CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer. Breast Cancer Res. 2007; 9(6):R87.
PMID:
18086299
; PMCID:
PMC2246190
.
Citations:
14
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Buzdar AU
, Valero V,
Ibrahim NK
, Francis D, Broglio KR, Theriault RL, Pusztai L, Green MC, Singletary SE,
Hunt KK
,
Sahin AA
, Esteva F,
Symmans WF
, Ewer MS,
Buchholz TA
, Hortobagyi GN. Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen. Clin Cancer Res. 2007 Jan 01; 13(1):228-33.
PMID:
17200359
.
Citations:
148
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Gonzalez RJ,
Buzdar AU
, Fraser Symmans W, Yen TW, Broglio KR,
Lucci A
, Esteva FJ, Yin G,
Kuerer HM
. Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin). Breast J. 2007 Jan-Feb; 13(1):72-5.
PMID:
17214797
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
Peintinger F,
Kuerer HM
, Anderson K, Boughey JC,
Meric-Bernstam F
, Singletary SE,
Hunt KK
,
Whitman GJ
, Stephens T,
Buzdar AU
, Green MC,
Symmans WF
. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol. 2006 Nov; 13(11):1443-9.
PMID:
17028770
.
Citations:
19
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Peintinger F,
Symmans WF
, Gonzalez-Angulo AM, Boughey JC,
Buzdar AU
, Yu TK,
Hunt KK
, Singletary SE,
Babiera GV
,
Lucci A
,
Meric-Bernstam F
,
Kuerer HM
. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer. 2006 Sep 15; 107(6):1248-54.
PMID:
16862596
.
Citations:
10
Fields:
Neo
Neoplasms
Translation:
Humans
Boughey JC, Peintinger F,
Meric-Bernstam F
, Perry AC,
Hunt KK
,
Babiera GV
, Singletary SE,
Bedrosian I
,
Lucci A
,
Buzdar AU
, Pusztai L,
Kuerer HM
. Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer. Ann Surg. 2006 Sep; 244(3):464-70.
PMID:
16926572
; PMCID:
PMC1856540
.
Citations:
34
Fields:
Gen
General Surgery
Translation:
Humans
Buzdar AU
, Robertson JF. Fulvestrant: pharmacologic profile versus existing endocrine agents for the treatment of breast cancer. Ann Pharmacother. 2006 Sep; 40(9):1572-83.
PMID:
16912252
.
Citations:
11
Fields:
Dru
Drug Therapy
Pha
Pharmacology
Translation:
Humans
Hess KR
, Anderson K,
Symmans WF
, Valero V,
Ibrahim N
, Mejia JA,
Booser D
, Theriault RL,
Buzdar AU
, Dempsey PJ, Rouzier R, Sneige N, Ross JS, Vidaurre T, Hortobagyi GN, Pusztai L, G?mez HL. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol. 2006 Sep 10; 24(26):4236-44.
PMID:
16896004
.
Citations:
264
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Guastalla JP, Nabholtz JM, Cuzick J. Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial. Cancer. 2006 Aug 01; 107(3):472-80.
PMID:
16804925
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar A
, Chlebowski R, Cuzick J, Duffy S, Forbes J, Jonat W, Ravdin P. Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer. Curr Med Res Opin. 2006 Aug; 22(8):1575-85.
PMID:
16870082
.
Citations:
6
Fields:
Med
Medicine (General)
Translation:
Humans
Arimidex, Tamoxifen, Alone or in Combination Trialists' Group,
Buzdar A
, Howell A, Cuzick J, Wale C, Distler W, Hoctin-Boes G, Houghton J, Locker GY, Nabholtz JM. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol. 2006 Aug; 7(8):633-43.
PMID:
16887480
.
Citations:
106
Fields:
Neo
Neoplasms
Translation:
Humans
Buchholz TA
,
Strom EA
, Oswald MJ,
Perkins GH
, Oh J, Domain D, Yu TK,
Woodward WA
,
Tereffe W
, Singletary SE, Thomas E,
Buzdar AU
, Hortobagyi GN, McNeese MD. Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1155-60.
PMID:
16750325
.
Citations:
3
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
PH
Public Health
CT
Clinical Trials
Hanrahan EO, Broglio K, Frye D,
Buzdar AU
, Theriault RL, Valero V,
Booser DJ
, Singletary SE,
Strom EA
, Gajewski JL,
Champlin RE
, Hortobagyi GN. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years. Cancer. 2006 Jun 01; 106(11):2327-36.
PMID:
16639731
.
Citations:
10
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Anastrozole for breast cancer: recent advances and ongoing challenges. Expert Rev Anticancer Ther. 2006 Jun; 6(6):839-48.
PMID:
16761927
.
Citations:
Fields:
Neo
Neoplasms
The
Therapeutics
Translation:
Humans
Cataliotti L,
Buzdar AU
, Noguchi S, Bines J, Takatsuka Y, Petrakova K, Dube P, de Oliveira CT. Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial. Cancer. 2006 May 15; 106(10):2095-103.
PMID:
16598749
.
Citations:
91
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Topoisomerase IIalpha gene amplification and response to anthracycline-containing adjuvant chemotherapy in breast cancer. J Clin Oncol. 2006 Jun 01; 24(16):2409-11.
PMID:
16682721
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. St Gallen guidelines: aromatase inhibitors recommended by name for adjuvant therapy. Ann Oncol. 2006 May; 17(5):878-9.
PMID:
16638951
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Update on the management of inflammatory breast cancer. Clin Adv Hematol Oncol. 2006 May; 4(5):344-5.
PMID:
16728943
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Chlebowski RT. Letrozole or tamoxifen in early breast cancer. N Engl J Med. 2006 Apr 06; 354(14):1528-30; author reply 1528-30.
PMID:
16602149
.
Citations:
Fields:
Med
Medicine (General)
Translation:
Humans
Buzdar AU
, Baum M, Cuzick J. Letrozole or tamoxifen in early breast cancer. N Engl J Med. 2006 Apr 06; 354(14):1528-30; author reply 1528-30.
PMID:
16598051
.
Citations:
Fields:
Med
Medicine (General)
Translation:
Humans
Guarneri V, Broglio K, Kau SW, Cristofanilli M,
Buzdar AU
, Valero V,
Buchholz T
, Meric F,
Middleton L
, Hortobagyi GN, Gonzalez-Angulo AM. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors. J Clin Oncol. 2006 Mar 01; 24(7):1037-44.
PMID:
16505422
.
Citations:
190
Fields:
Neo
Neoplasms
Translation:
Humans
Hennessy BT, Gonzalez-Angulo AM, Hortobagyi GN, Cristofanilli M, Kau SW, Broglio K,
Fornage B
, Singletary SE,
Sahin A
,
Buzdar AU
, Valero V. Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy. Cancer. 2006 Mar 01; 106(5):1000-6.
PMID:
16444747
.
Citations:
10
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. Dietary modification and risk of breast cancer. JAMA. 2006 Feb 08; 295(6):691-2.
PMID:
16467239
.
Citations:
Fields:
Med
Medicine (General)
Translation:
Humans
Chagpar AB,
Middleton LP
,
Sahin AA
, Dempsey P,
Buzdar AU
, Mirza AN, Ames FC,
Babiera GV
,
Feig BW
,
Hunt KK
,
Kuerer HM
,
Meric-Bernstam F
,
Ross MI
, Singletary SE. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg. 2006 Feb; 243(2):257-64.
PMID:
16432360
; PMCID:
PMC1448900
.
Citations:
66
Fields:
Gen
General Surgery
Translation:
Humans
Paik S. Methods for gene expression profiling in clinical trials of adjuvant breast cancer therapy. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 2):1019s-1023s.
PMID:
16467119
.
Citations:
9
Fields:
Neo
Neoplasms
Translation:
Humans
Come SE,
Buzdar AU
, Ingle JN, Arteaga CL, Brown M, Dowsett M,
Hilsenbeck SG
, Kumar R, Johnston SR, Lee AV, Paik S, Pritchard KI, Winer EP, Hart C. Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 2):997s-1000s.
PMID:
16467115
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Kim HJ, Cui X,
Hilsenbeck SG
, Lee AV. Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 2):1013s-1018s.
PMID:
16467118
.
Citations:
29
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Hilsenbeck SG
,
Osborne CK
. Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An in silico clinical trial. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 2):1049s-1055s.
PMID:
16467123
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Dowsett M, Smith IE, Ebbs SR, Dixon JM, Skene A, Griffith C, Boeddinghaus I, Salter J, Detre S, Hills M, Ashley S, Francis S, Walsh G, A'Hern R. Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 2):1024s-1030s.
PMID:
16467120
.
Citations:
42
Fields:
Neo
Neoplasms
Translation:
Humans
Ingle JN. Adjuvant endocrine therapy for postmenopausal women with early breast cancer. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 2):1031s-1036s.
PMID:
16467121
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Cuzick J. Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: emerging data. Clin Cancer Res. 2006 Feb 01; 12(3 Pt 2):1037s-1048s.
PMID:
16467122
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Hennessy BT, Hortobagyi GN, Rouzier R,
Kuerer H
, Sneige N,
Buzdar AU
, Kau SW,
Fornage B
,
Sahin A
, Broglio K, Singletary SE, Valero V. Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol. 2005 Dec 20; 23(36):9304-11.
PMID:
16361629
.
Citations:
100
Fields:
Neo
Neoplasms
Translation:
Humans
Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y, Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005 Dec 17; 366(9503):2087-106.
PMID:
16360786
.
Citations:
1274
Fields:
Med
Medicine (General)
Translation:
Humans
Giordano SH
,
Perkins GH
, Broglio K, Garcia SG,
Middleton LP
,
Buzdar AU
, Hortobagyi GN. Adjuvant systemic therapy for male breast carcinoma. Cancer. 2005 Dec 01; 104(11):2359-64.
PMID:
16270318
.
Citations:
48
Fields:
Neo
Neoplasms
Translation:
Humans
Rouzier R, Pusztai L, Delaloge S, Gonzalez-Angulo AM, Andre F,
Hess KR
,
Buzdar AU
, Garbay JR, Spielmann M, Mathieu MC,
Symmans WF
, Wagner P, Atallah D, Valero V,
Berry DA
, Hortobagyi GN. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J Clin Oncol. 2005 Nov 20; 23(33):8331-9.
PMID:
16293864
.
Citations:
82
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Cuzick J. Optimum use of aromatase inhibitors in the adjuvant treatment of early breast cancer. J Clin Oncol. 2005 Nov 20; 23(33):8544-6; author reply 8546-7.
PMID:
16293888
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Yamaya H, Saeki M, Yoshida K, Shibata J, Yano S, Sato Y, Takao A, Shindo T,
Buzdar AU
, Nagayama S. Distribution of (7alpha)-21-[4-[(diethylamino) methyl]-2-methoxyphenoxy]-7-methyl-19-norpregna-1,3,5(10)-trien-3-ol-20-[14C]2-hydroxy-1,2,3-propanetricarboxylate ([14C]TAS-108) and its metabolites after single oral administration to rats bearing 7,12-dimethylbenz(alpha)anthracene-induced mammary tumor. Drug Metab Dispos. 2006 Feb; 34(2):331-8.
PMID:
16299166
.
Citations:
Fields:
Pha
Pharmacology
Translation:
Animals
Duffy S, Jackson TL, Lansdown M, Philips K, Wells M, Pollard S, Clack G, Coibion M, Bianco AR. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment. Hum Reprod. 2006 Feb; 21(2):545-53.
PMID:
16210385
.
Citations:
8
Fields:
Rep
Reproductive Medicine
Translation:
Humans
Gonzalez-Angulo AM,
McGuire SE
,
Buchholz TA
, Tucker SL,
Kuerer HM
, Rouzier R, Kau SW, Huang EH, Morandi P, Ocana A, Cristofanilli M, Valero V,
Buzdar AU
, Hortobagyi GN. Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy. J Clin Oncol. 2005 Oct 01; 23(28):7098-104.
PMID:
16192593
.
Citations:
32
Fields:
Neo
Neoplasms
Translation:
Humans
Yamaya H, Yoshida K, Kuritani J, Yonezawa J, Yonezawa JI, Tsuda M, Shindo T, Nagayama S,
Buzdar AU
. Safety, tolerability, and pharmacokinetics of TAS-108 in normal healthy post-menopausal female subjects: a phase I study on single oral dose. J Clin Pharm Ther. 2005 Oct; 30(5):459-70.
PMID:
16164493
.
Citations:
1
Fields:
Pha
Pharmacy
The
Therapeutics
Translation:
Humans
CT
Clinical Trials
Hanrahan EO, Broglio KR,
Buzdar AU
, Theriault RL, Valero V, Cristofanilli M, Yin G, Kau SW, Hortobagyi GN, Rivera E. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors. Cancer. 2005 Sep 15; 104(6):1158-71.
PMID:
16047352
.
Citations:
19
Fields:
Neo
Neoplasms
Translation:
Humans
Green MC,
Buzdar AU
, Smith T,
Ibrahim NK
, Valero V, Rosales MF, Cristofanilli M,
Booser DJ
, Pusztai L, Rivera E, Theriault RL, Carter C, Frye D,
Hunt KK
,
Symmans WF
,
Strom EA
,
Sahin AA
, Sikov W, Hortobagyi GN. Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks. J Clin Oncol. 2005 Sep 01; 23(25):5983-92.
PMID:
16087943
.
Citations:
100
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Montero AJ, Rouzier R, Lluch A, Theriault RL,
Buzdar AU
, Delaloge S, Le M, Kau SW, Dunant A, Arriagada R, Spielmann M, Garcia-Conde J,
Sahin AA
, Singletary SE, Hortobagyi GN, Valero V, Bermejo B. The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study. Cancer. 2005 Jul 15; 104(2):229-35.
PMID:
15937910
.
Citations:
9
Fields:
Neo
Neoplasms
Translation:
Humans
Gonzalez-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, Theriault R,
Booser D
,
Buzdar AU
, Hortobagyi GN,
Arun B
. Women age < or = 35 years with primary breast carcinoma: disease features at presentation. Cancer. 2005 Jun 15; 103(12):2466-72.
PMID:
15852360
.
Citations:
25
Fields:
Neo
Neoplasms
Translation:
Humans
Huang EH, Tucker SL,
Strom EA
, McNeese MD,
Kuerer HM
, Hortobagyi GN,
Buzdar AU
, Valero V,
Perkins GH
, Schechter NR,
Hunt KK
,
Sahin AA
,
Buchholz TA
. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Jun 01; 62(2):351-7.
PMID:
15890574
.
Citations:
33
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
Buzdar AU
,
Ibrahim NK
, Francis D,
Booser DJ
, Thomas ES, Theriault RL, Pusztai L, Green MC,
Arun BK
,
Giordano SH
, Cristofanilli M, Frye DK, Smith TL,
Hunt KK
, Singletary SE,
Sahin AA
, Ewer MS,
Buchholz TA
,
Berry D
, Hortobagyi GN. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol. 2005 Jun 01; 23(16):3676-85.
PMID:
15738535
.
Citations:
311
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Howell A,
Buzdar A
. Are aromatase inhibitors superior to antiestrogens? J Steroid Biochem Mol Biol. 2005 Feb; 93(2-5):237-47.
PMID:
15860266
.
Citations:
7
Fields:
Bio
Biochemistry
Mol
Molecular Biology
Translation:
Humans
Johnston SR. Combinations of endocrine and biological agents: present status of therapeutic and presurgical investigations. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 2):889s-99s.
PMID:
15701883
.
Citations:
13
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Ingle JN. Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 2):900s-5s.
PMID:
15701884
.
Citations:
9
Fields:
Neo
Neoplasms
Translation:
Humans
L?nning PE. Exemestane for breast cancer prevention: a feasible strategy? Clin Cancer Res. 2005 Jan 15; 11(2 Pt 2):918s-24s.
PMID:
15701887
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Anderson WF, Devesa SS. Breast carcinoma in men. Cancer. 2005 Jan 15; 103(2):432-3; author reply 433.
PMID:
15578682
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
PH
Public Health
Buzdar AU
. TAS-108: a novel steroidal antiestrogen. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 2):906s-8s.
PMID:
15701885
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
Yue W, Wang JP, Li Y, Bocchinfuso WP, Korach KS, Devanesan PD, Rogan E, Cavalieri E, Santen RJ. Tamoxifen versus aromatase inhibitors for breast cancer prevention. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 2):925s-30s.
PMID:
15701888
.
Citations:
16
Fields:
Neo
Neoplasms
Translation:
Humans
Animals
Come SE,
Buzdar AU
, Ingle JN, Arteaga CL, Brodie AM, Colditz GA, Johnston SR, Kristensen VN, McDonnell DP,
Osborne CK
, Russo J, Santen RJ, Yee D, Hart CS, L?nning PE. Proceedings of the Fourth International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 2):861s-4s.
PMID:
15701878
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Cristofanilli M, Gonzalez-Angulo A, Sneige N, Kau SW, Broglio K, Theriault RL, Valero V,
Buzdar AU
,
Kuerer H
,
Buchholz TA
, Buccholz TA, Hortobagyi GN. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol. 2005 Jan 01; 23(1):41-8.
PMID:
15625359
.
Citations:
86
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar A
, Macahilig C. How rapidly do oncologists respond to clinical trial data? Oncologist. 2005 Jan; 10(1):15-21.
PMID:
15632249
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Yamamoto Y, Shibata J, Yonekura K, Sato K, Hashimoto A, Aoyagi Y, Wierzba K, Yano S, Asao T,
Buzdar AU
, Terada T. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect. Clin Cancer Res. 2005 Jan 01; 11(1):315-22.
PMID:
15671561
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Buzdar AU
. Aromatase inhibitors: changing the face of endocrine therapy for breast cancer. Breast Dis. 2005-2006; 24:107-17.
PMID:
16917143
.
Citations:
3
Fields:
Gyn
Gynecology
Translation:
Humans
Howell A, Cuzick J, Baum M,
Buzdar A
, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, ATAC Trialists' Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet. 2005 Jan 1-7; 365(9453):60-2.
PMID:
15639680
.
Citations:
541
Fields:
Med
Medicine (General)
Translation:
Humans
Huang EH, Tucker SL,
Strom EA
, McNeese MD,
Kuerer HM
,
Buzdar AU
, Valero V,
Perkins GH
, Schechter NR,
Hunt KK
,
Sahin AA
, Hortobagyi GN,
Buchholz TA
. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol. 2004 Dec 01; 22(23):4691-9.
PMID:
15570071
.
Citations:
56
Fields:
Neo
Neoplasms
Translation:
Humans
Yu TK,
Whitman GJ
, Thames HD,
Buzdar AU
,
Strom EA
,
Perkins GH
, Schechter NR, McNeese MD, Kau SW, Thomas ES, Hortobagyi GN,
Buchholz TA
. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J Natl Cancer Inst. 2004 Nov 17; 96(22):1676-81.
PMID:
15547180
.
Citations:
17
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Gonzalez-Angulo AM, Cristofanilli M,
Strom EA
,
Buzdar AU
, Kau SW, Broglio KR, Smith TL, Hortobagyi GN. Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment. Cancer. 2004 Oct 15; 101(8):1760-6.
PMID:
15386311
.
Citations:
24
Fields:
Neo
Neoplasms
Translation:
Humans
Li Z,
Ibrahim NK
, Wathen JK,
Wang M
, Mante Menchu RP,
Valero V
, Theriault R,
Buzdar AU
, Hortobagyi GN. Colitis in patients with breast carcinoma treated with taxane-based chemotherapy. Cancer. 2004 Oct 01; 101(7):1508-13.
PMID:
15378497
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
Morandi P, Rouzier R, Altundag K,
Buzdar AU
, Theriault RL, Hortobagyi G. The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach. Cancer. 2004 Oct 01; 101(7):1482-9.
PMID:
15378476
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Gonzalez-Angulo AM, Sneige N,
Buzdar AU
, Valero V, Kau SW, Broglio K, Yamamura Y, Hortobagyi GN, Cristofanilli M. p53 expression as a prognostic marker in inflammatory breast cancer. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 1):6215-21.
PMID:
15448010
.
Citations:
11
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Buzdar AU
. Current developments in hormonal therapy of breast cancer. Clin Breast Cancer. 2004 Sep; 5 Suppl 1:S4-5.
PMID:
15347432
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Resetkova E
, Gonzalez-Angulo AM, Sneige N,
Mcdonnell TJ
,
Buzdar AU
, Kau SW, Yamamura Y, Reuben JM, Hortobagyi GN, Cristofanilli M. Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma. Cancer. 2004 Sep 01; 101(5):913-7.
PMID:
15329897
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Buzdar AU
. Fulvestrant: a new type of estrogen receptor antagonist for the treatment of advanced breast cancer. Drugs Today (Barc). 2004 Sep; 40(9):751-64.
PMID:
15538548
.
Citations:
3
Fields:
Dru
Drug Therapy
Translation:
Humans
Animals
Jones KL,
Buzdar AU
. A review of adjuvant hormonal therapy in breast cancer. Endocr Relat Cancer. 2004 Sep; 11(3):391-406.
PMID:
15369444
.
Citations:
17
Fields:
End
Endocrinology
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. The ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial: an update. Clin Breast Cancer. 2004 Sep; 5 Suppl 1:S6-S12.
PMID:
15347433
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
Blakely LJ,
Buzdar A
, Chang HY, Frye D, Theriault R, Valero V, Rivera E,
Booser D
, Kuritani J, Tsuda M. A phase I and pharmacokinetic study of TAS-108 in postmenopausal female patients with locally advanced, locally recurrent inoperable, or progressive metastatic breast cancer. Clin Cancer Res. 2004 Aug 15; 10(16):5425-31.
PMID:
15328180
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Wefel JS
,
Lenzi R
, Theriault R,
Buzdar AU
, Cruickshank S, Meyers CA. 'Chemobrain' in breast carcinoma?: a prologue. Cancer. 2004 Aug 01; 101(3):466-75.
PMID:
15274059
.
Citations:
106
Fields:
Neo
Neoplasms
Translation:
Humans
Buchholz TA
, Huang EH,
Berry D
, Pusztai L,
Strom EA
, McNeese MD,
Perkins GH
, Schechter NR,
Kuerer HM
,
Buzdar AU
, Valero V,
Hunt KK
, Hortobagyi GN,
Sahin AA
. Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys. 2004 Aug 01; 59(5):1337-42.
PMID:
15275718
.
Citations:
9
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
Buzdar AU
. Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the international letrozole breast cancer group. J Clin Oncol. 2004 Aug 01; 22(15):3199-200; author reply 3200-1.
PMID:
15284276
.
Citations:
9
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Gonzalez-Angulo AM,
Krishnamurthy S
, Yamamura Y, Broglio KR, Pusztai L,
Buzdar AU
, Hortobagyi GN, Esteva FJ. Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinoma. Cancer. 2004 Jul 15; 101(2):258-63.
PMID:
15241821
.
Citations:
11
Fields:
Neo
Neoplasms
Translation:
Humans
Giordano SH
, Cohen DS,
Buzdar AU
,
Perkins G
, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004 Jul 01; 101(1):51-7.
PMID:
15221988
.
Citations:
233
Fields:
Neo
Neoplasms
Translation:
Humans
Thomas E, Holmes FA, Smith TL,
Buzdar AU
, Frye DK, Fraschini G, Singletary SE, Theriault RL, McNeese MD, Ames F,
Walters R
, Hortobagyi GN. The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial. J Clin Oncol. 2004 Jun 15; 22(12):2294-302.
PMID:
15197190
.
Citations:
33
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Schwartz GF, Hortobagyi GN. Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania. Cancer. 2004 Jun 15; 100(12):2512-32.
PMID:
15197792
.
Citations:
29
Fields:
Neo
Neoplasms
Buzdar AU
, Vergote I, Sainsbury R. The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women. Breast J. 2004 May-Jun; 10(3):211-7.
PMID:
15125747
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Garg AK
,
Strom EA
, McNeese MD,
Buzdar AU
, Hortobagyi GN,
Kuerer HM
,
Perkins GH
, Singletary SE,
Hunt KK
,
Sahin A
, Schechter N, Valero V, Tucker SL,
Buchholz TA
. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):138-45.
PMID:
15093909
.
Citations:
14
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
Cuzick J,
Buzdar A
, Baum M, Bianco R,
Coleman R
, Constenla M, Distler W, Dowsett M, Forbes J, Guastalla JP, Houghton J, Williams N, Howell A, Locker G, MacKey J, Sainsbury R, Tobias J. Adjuvant use of anastrozole in breast cancer. J Clin Oncol. 2004 Apr 15; 22(8):1524-6; author reply 1526-7.
PMID:
15084628
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Preoperative chemotherapy for breast cancer. Clin Adv Hematol Oncol. 2004 Apr; 2(4):212, 215.
PMID:
16163183
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Rajan R, Poniecka A, Smith TL, Yang Y, Frye D, Pusztai L, Fiterman DJ, Gal-Gombos E,
Whitman G
, Rouzier R, Green M,
Kuerer H
,
Buzdar AU
, Hortobagyi GN,
Symmans WF
. Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response. Cancer. 2004 Apr 01; 100(7):1365-73.
PMID:
15042669
.
Citations:
51
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. Letrozole in breast cancer. N Engl J Med. 2004 Feb 12; 350(7):727-30; author reply 727-30.
PMID:
14960751
.
Citations:
1
Fields:
Med
Medicine (General)
Translation:
Humans
Blakely LJ,
Buzdar AU
, Lozada JA, Shullaih SA, Hoy E, Smith TL, Hortobagyi GN. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer. 2004 Feb 01; 100(3):465-9.
PMID:
14745861
.
Citations:
40
Fields:
Neo
Neoplasms
Translation:
Humans
Esteva FJ,
Sahin AA
, Smith TL, Yang Y, Pusztai L, Nahta R,
Buchholz TA
,
Buzdar AU
, Hortobagyi GN, Bacus SS. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma. Cancer. 2004 Feb 01; 100(3):499-506.
PMID:
14745865
.
Citations:
48
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Cristofanilli M, Gonzalez-Angulo AM,
Buzdar AU
, Kau SW, Frye DK, Hortobagyi GN. Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience. Clin Breast Cancer. 2004 Feb; 4(6):415-9.
PMID:
15023242
.
Citations:
19
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 2):355S-61S.
PMID:
14734491
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
Ellis MJ. Neoadjuvant endocrine therapy as a drug development strategy. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 2):391S-5S.
PMID:
14734497
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Giordano SH
,
Buzdar AU
, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving? Cancer. 2004 Jan 01; 100(1):44-52.
PMID:
14692023
.
Citations:
151
Fields:
Neo
Neoplasms
Translation:
Humans
Come SE,
Buzdar AU
, Arteaga CL, Bissell MJ, Brown MA, Ellis MJ, Goss PE, Green JE, Ingle JN, Lee AV, Medina D, Nicholson RI, Santen RJ,
Schiff R
, Hart CS. Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 2):327S-330S.
PMID:
14734487
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Buzdar AU
. Paclitaxel in early breast cancer: a viewpoint by Aman U. Buzdar. Drugs. 2004; 64(16):1848-9.
PMID:
15301566
.
Citations:
Fields:
Dru
Drug Therapy
Pha
Pharmacology
Translation:
Humans
Cameron DA. Paclitaxel in early breast cancer: a viewpoint by David A. Cameron. Drugs. 2004; 64(16):1848-9.
PMID:
15301567
.
Citations:
Fields:
Dru
Drug Therapy
Pha
Pharmacology
Translation:
Humans
Buzdar AU
. Hormonal therapy in early and advanced breast cancer. Breast J. 2004 Jan-Feb; 10 Suppl 1:S19-21.
PMID:
14984485
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Simons WR, Jones D,
Buzdar A
. Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer. Clin Ther. 2003 Nov; 25(11):2972-87.
PMID:
14693319
.
Citations:
4
Fields:
Dru
Drug Therapy
The
Therapeutics
Translation:
Humans
Robertson JF, Nabholtz JM,
Buzdar A
, Bonneterre J, Arimidex Study Group, Th?rlimann B. Efficacy of tamoxifen following anastrozole ('Arimidex') compared with anastrozole following tamoxifen as first-line treatment for advanced breast cancer in postmenopausal women. Eur J Cancer. 2003 Nov; 39(16):2310-7.
PMID:
14556922
.
Citations:
11
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Aromatase inhibitors in breast cancer therapy. Clin Breast Cancer. 2003 Nov; 4 Suppl 2:S84-8.
PMID:
14667279
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Baum M,
Buzdar A
, Cuzick J, Forbes J, Houghton J, Howell A, Sahmoud T, ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer. 2003 Nov 01; 98(9):1802-10.
PMID:
14584060
.
Citations:
179
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Baum M,
Buzdar A
, Howell A. ATAC trial did not report interim results. BMJ. 2003 Nov 01; 327(7422):1050.
PMID:
14593064
; PMCID:
PMC261674
.
Citations:
Fields:
Med
Medicine (General)
Translation:
Humans
Buzdar AU
. Breast cancer in men. Oncology (Williston Park). 2003 Oct; 17(10):1361-4; discussion 1364, 1369-72.
PMID:
14606362
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Role of anastrozole in adjuvant therapy for postmenopausal patients. Semin Oncol. 2003 Oct; 30(5 Suppl 16):21-9.
PMID:
14613023
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Woodward WA
,
Strom EA
, Tucker SL, Katz A, McNeese MD,
Perkins GH
,
Buzdar AU
, Hortobagyi GN,
Hunt KK
,
Sahin A
, Meric F, Sneige N,
Buchholz TA
. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):336-44.
PMID:
12957243
.
Citations:
24
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
Woodward WA
,
Strom EA
, McNeese MD,
Perkins GH
, Outlaw EL, Hortobagyi GN,
Buzdar AU
,
Buchholz TA
. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):327-35.
PMID:
12957242
.
Citations:
13
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
Buzdar AU
, Hortobagyi GN. Sequential paclitaxel reduces recurrence and mortality in women with early breast cancer. Cancer Treat Rev. 2003 Oct; 29(5):449-52.
PMID:
12972364
.
Citations:
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, ATAC trialists' group. 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer--efficacy overview. J Steroid Biochem Mol Biol. 2003 Sep; 86(3-5):399-403.
PMID:
14623537
.
Citations:
5
Fields:
Bio
Biochemistry
Mol
Molecular Biology
Translation:
Humans
CT
Clinical Trials
Baum M,
Buzdar A
. The current status of aromatase inhibitors in the management of breast cancer. Surg Clin North Am. 2003 Aug; 83(4):973-94.
PMID:
12875605
.
Citations:
3
Fields:
Gen
General Surgery
Translation:
Humans
Nabholtz JM, Bonneterre J,
Buzdar A
, Robertson JF, Th?rlimann B. Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results. Eur J Cancer. 2003 Aug; 39(12):1684-9.
PMID:
12888362
.
Citations:
39
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Robertson JF,
Osborne CK
, Howell A, Jones SE, Mauriac L, Ellis M, Kleeberg UR, Come SE, Vergote I, Gertler S,
Buzdar A
, Webster A, Morris C. Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials. Cancer. 2003 Jul 15; 98(2):229-38.
PMID:
12872340
.
Citations:
68
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Symmans WF
, Ayers M, Clark EA, Stec J,
Hess KR
, Sneige N,
Buchholz TA
,
Krishnamurthy S
,
Ibrahim NK
,
Buzdar AU
, Theriault RL, Rosales MF, Thomas ES, Gwyn KM, Green MC, Syed AR, Hortobagyi GN, Pusztai L. Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma. Cancer. 2003 Jun 15; 97(12):2960-71.
PMID:
12784330
.
Citations:
48
Fields:
Neo
Neoplasms
Translation:
Humans
Assikis V,
Buzdar A
, Yang Y, Smith T, Theriault R,
Booser D
, Valero V,
Walters R
, Singletary E, Ames F, Hortobagyi G. A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up. Cancer. 2003 Jun 01; 97(11):2716-23.
PMID:
12767083
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Allred DC, Baum M,
Buzdar AU
, Carlson RW, Dowsett M, Elledge RM, Gradishar WJ, Grana G, Howell A, Mamounas EP. A roundtable discussion of aromatase inhibitors as therapy for breast cancer. Breast J. 2003 May-Jun; 9(3):213-22.
PMID:
12752630
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Montemurro F, Munsell M, Smith TL, Donato ML, Gajewski JL, Rahman ZU,
Buzdar AU
,
Champlin RE
,
Ueno NT
, Rond?n G. Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection. Biol Blood Marrow Transplant. 2003 May; 9(5):330-40.
PMID:
12766883
.
Citations:
2
Fields:
Hem
Hematology
Tra
Transplantation
Translation:
Humans
Zhang F, Yang Y, Smith T, Kau SW, McConathy JM, Esteva FJ,
Kuerer HM
,
Symmans WF
,
Buzdar AU
, Hortobagyi GN, Pusztai L. Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma. Cancer. 2003 Apr 01; 97(7):1758-65.
PMID:
12655533
.
Citations:
18
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar A
. Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trial. Clin Breast Cancer. 2003 Apr; 4 Suppl 1:S42-8.
PMID:
12756078
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar A
, O'Shaughnessy JA,
Booser DJ
, Pippen JE, Jones SE, Munster PN, Peterson P, Melemed AS, Winer E, Hudis C. Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer. J Clin Oncol. 2003 Mar 15; 21(6):1007-14.
PMID:
12637464
.
Citations:
17
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Hess KR
, Pusztai L,
Buzdar AU
, Hortobagyi GN. Estrogen receptors and distinct patterns of breast cancer relapse. Breast Cancer Res Treat. 2003 Mar; 78(1):105-18.
PMID:
12611463
.
Citations:
78
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer. Oncologist. 2003; 8(4):335-41.
PMID:
12897330
.
Citations:
14
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Pharmacology and pharmacokinetics of the newer generation aromatase inhibitors. Clin Cancer Res. 2003 Jan; 9(1 Pt 2):468S-72S.
PMID:
12538502
.
Citations:
10
Fields:
Neo
Neoplasms
Translation:
Humans
Cristofanilli M,
Buzdar AU
, Hortob?gyi GN. Update on the management of inflammatory breast cancer. Oncologist. 2003; 8(2):141-8.
PMID:
12697939
.
Citations:
32
Fields:
Neo
Neoplasms
Translation:
Humans
Come SE,
Buzdar AU
, Arteaga CL, Brodie AM, Davidson NE, Dowsett M, Ingle JN, Johnston SR, Lee AV,
Osborne CK
, Pritchard KI, Vogel VG, Winer EP, Hart CS. Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement. Clin Cancer Res. 2003 Jan; 9(1 Pt 2):443S-6S.
PMID:
12538498
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Anastrozole (Arimidex) in clinical practice versus the old 'gold standard', tamoxifen. Expert Rev Anticancer Ther. 2002 Dec; 2(6):623-9.
PMID:
12503208
.
Citations:
2
Fields:
Neo
Neoplasms
The
Therapeutics
Translation:
Humans
Gluck S. Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor-positive advanced breast carcinoma. Cancer. 2002 Dec 01; 95(11):2442-3; author reply 2443-4.
PMID:
12436453
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Robertson JF, Eiermann W, Nabholtz JM. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane. Cancer. 2002 Nov 01; 95(9):2006-16.
PMID:
12404296
.
Citations:
44
Fields:
Neo
Neoplasms
Translation:
Humans
Giordano SH
,
Booser DJ
, Murray JL,
Ibrahim NK
, Rahman ZU, Valero V, Theriault RL, Rosales MF, Rivera E, Frye D, Ewer M, Ordonez NG,
Buzdar AU
, Hortobagyi GN. A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer. Clin Cancer Res. 2002 Nov; 8(11):3360-8.
PMID:
12429622
.
Citations:
19
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Giordano SH
,
Buzdar AU
, Hortobagyi GN. Breast cancer in men. Ann Intern Med. 2002 Oct 15; 137(8):678-87.
PMID:
12379069
.
Citations:
96
Fields:
Int
Internal Medicine
Translation:
Humans
Valero V
,
Buzdar AU
, McNeese M, Singletary E, Hortobagyi GN. Primary chemotherapy in the treatment of breast cancer: the University of Texas M. D. Anderson Cancer Center experience. Clin Breast Cancer. 2002 Oct; 3 Suppl 2:S63-8.
PMID:
12435294
.
Citations:
9
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. New generation aromatase inhibitors--from the advanced to the adjuvant setting. Breast Cancer Res Treat. 2002 Oct; 75 Suppl 1:S13-7; discussion S33-5.
PMID:
12353818
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Osborne CK
, Pippen J, Jones SE, Parker LM, Ellis M, Come S, Gertler SZ, May JT, Burton G, Dimery I, Webster A, Morris C, Elledge R,
Buzdar A
. Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial. J Clin Oncol. 2002 Aug 15; 20(16):3386-95.
PMID:
12177098
.
Citations:
131
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Huang E, McNeese MD,
Strom EA
,
Perkins GH
, Katz A, Hortobagyi GN, Valero V,
Kuerer HM
, Singletary SE,
Hunt KK
,
Buzdar AU
,
Buchholz TA
. Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys. 2002 Aug 01; 53(5):1225-33.
PMID:
12128124
.
Citations:
12
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
Buchholz TA
, Katz A,
Strom EA
, McNeese MD,
Perkins GH
, Hortobagyi GN, Thames HD,
Kuerer HM
, Singletary SE,
Sahin AA
,
Hunt KK
,
Buzdar AU
, Valero V, Sneige N, Tucker SL. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 2002 Jul 15; 53(4):880-8.
PMID:
12095553
.
Citations:
13
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, Sahmoud T, ATAC Trialists' Group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet. 2002 Jun 22; 359(9324):2131-9.
PMID:
12090977
.
Citations:
422
Fields:
Med
Medicine (General)
Translation:
Humans
CT
Clinical Trials
Giordano SH
, Valero V,
Buzdar AU
, Hortobagyi GN. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol. 2002 Jun; 25(3):235-7.
PMID:
12040279
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
Assikis VJ,
Buzdar A
. Recent advances in aromatase inhibitor therapy for breast cancer. Semin Oncol. 2002 Jun; 29(3 Suppl 11):120-8.
PMID:
12138406
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Singletary SE, Valero V,
Booser DJ
,
Ibrahim NK
, Rahman Z, Theriault RL,
Walters R
, Rivera E, Smith TL, Holmes FA, Hoy E, Frye DK, Manuel N, Kau SW, McNeese MD,
Strom E
, Thomas E,
Hunt K
, Ames F,
Berry D
, Hortobagyi GN. Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial. Clin Cancer Res. 2002 May; 8(5):1073-9.
PMID:
12006521
.
Citations:
28
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar A
, Hayes D, El-Khoudary A, Yan S, Lichinitser M, Gopal R, Falkson G, Pritchard K, Lipton A, Wolter K, Lee A, Fly K, Chew R, Alderdice M, Burke K, Eisenber P, Droloxifene 301 Study Group, L?nning P. Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer. Breast Cancer Res Treat. 2002 May; 73(2):161-75.
PMID:
12088118
.
Citations:
10
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Newman LA,
Buzdar AU
, Singletary SE,
Kuerer HM
,
Buchholz T
, Ames FC,
Ross MI
,
Hunt KK
. A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol. 2002 Apr; 9(3):228-34.
PMID:
11923128
.
Citations:
22
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. Superior efficacy of letrozole versus tamoxifen as first-line therapy. J Clin Oncol. 2002 Feb 01; 20(3):876-8.
PMID:
11821477
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Rivera E, Holmes FA,
Buzdar AU
, Asmar L, Kau SW, Fraschini G,
Walters R
, Theriault RL, Hortobagyi GN. Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease. Breast J. 2002 Jan-Feb; 8(1):2-9.
PMID:
11856154
.
Citations:
8
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buchholz TA
, Tucker SL, Masullo L,
Kuerer HM
, Erwin J, Salas J, Frye D,
Strom EA
, McNeese MD,
Perkins G
, Katz A, Singletary SE,
Hunt KK
,
Buzdar AU
, Hortobagyi GN. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol. 2002 Jan 01; 20(1):17-23.
PMID:
11773149
.
Citations:
32
Fields:
Neo
Neoplasms
Translation:
Humans
Mackey JR, Joy AA. Letrozole in second-line therapy of advanced breast cancer: more questions than answers. J Clin Oncol. 2001 Dec 01; 19(23):4353-5.
PMID:
11731524
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Johnson PE,
Buzdar A
. Are differences in the available aromatase inhibitors and inactivators significant? Clin Cancer Res. 2001 Dec; 7(12 Suppl):4360s-4368s; discussion 4411s-4412s.
PMID:
11916226
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Come SE, Brodie A, Ellis M, Goss PE, Ingle JN, Johnston SR, Lee AV,
Osborne CK
, Vogel VG, Hart CS. Proceedings of the First International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: summary consensus statement. Clin Cancer Res. 2001 Dec; 7(12 Suppl):4335s-4337s; discussion 4411s-4412s.
PMID:
11916221
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Kuerer HM
, Singletary SE,
Buzdar AU
, Ames FC,
Valero V
,
Buchholz TA
, Ross MI, Pusztai L, Hortobagyi GN,
Hunt KK
. Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg. 2001 Dec; 182(6):601-8.
PMID:
11839324
.
Citations:
18
Fields:
Gen
General Surgery
Translation:
Humans
Vogel VG. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts. Clin Cancer Res. 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s.
PMID:
11916233
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. A summary of second-line randomized studies of aromatase inhibitors. J Steroid Biochem Mol Biol. 2001 Dec; 79(1-5):109-14.
PMID:
11850214
.
Citations:
3
Fields:
Bio
Biochemistry
Mol
Molecular Biology
Translation:
Humans
Johnston SR. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies. Clin Cancer Res. 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s.
PMID:
11916228
.
Citations:
14
Fields:
Neo
Neoplasms
Translation:
Humans
Goss PE. Preliminary data from ongoing adjuvant aromatase inhibitor trials. Clin Cancer Res. 2001 Dec; 7(12 Suppl):4397s-4401s; discussion 4411s-4412s.
PMID:
11916231
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Xiong Q,
Valero V
, Kau V, Kau SW, Taylor S, Smith TL,
Buzdar AU
, Hortobagyi GN, Theriault RL. Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer. 2001 Nov 15; 92(10):2523-8.
PMID:
11745185
.
Citations:
56
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Anastrozole (Arimidex)--an aromatase inhibitor for the adjuvant setting? Br J Cancer. 2001 Nov; 85 Suppl 2:6-10.
PMID:
11900212
; PMCID:
PMC2375168
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Bonneterre J,
Buzdar A
, Nabholtz JM, Robertson JF, von Euler M, Sahmoud T, Webster A, Steinberg M, Arimidex Writing Committee, Investigators Committee Members, Th?rlimann B. Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Cancer. 2001 Nov 01; 92(9):2247-58.
PMID:
11745278
.
Citations:
99
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Blum JL, Dieras V, Lo Russo PM, Horton J, Rutman O,
Buzdar A
, Osterwalder B. Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients. Cancer. 2001 Oct 01; 92(7):1759-68.
PMID:
11745247
.
Citations:
78
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Cristofanilli M,
Buzdar AU
, Sneige N, Smith T, Wasaff B,
Ibrahim N
,
Booser D
, Rivera E, Murray JL,
Valero V
,
Ueno N
, Singletary ES,
Hunt K
,
Strom E
, McNeese M, Stelling C, Hortobagyi GN. Paclitaxel in the multimodality treatment for inflammatory breast carcinoma. Cancer. 2001 Oct 01; 92(7):1775-82.
PMID:
11745249
.
Citations:
14
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buchholz TA
, Hill BS, Tucker SL, Frye DK,
Kuerer HM
,
Buzdar AU
, McNeese MD, Singletary SE,
Ueno NT
, Pusztai L,
Valero V
, Hortobagyi GN. Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. Cancer J. 2001 Sep-Oct; 7(5):413-20.
PMID:
11693900
.
Citations:
16
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar A
, Howell A. Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. Clin Cancer Res. 2001 Sep; 7(9):2620-35.
PMID:
11555572
.
Citations:
23
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar A
, Douma J, Davidson N, Elledge R, Morgan M, Smith R, Porter L, Nabholtz J, Xiang X, Brady C. Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. J Clin Oncol. 2001 Jul 15; 19(14):3357-66.
PMID:
11454883
.
Citations:
61
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. Endocrine therapy in the treatment of metastatic breast cancer. Semin Oncol. 2001 Jun; 28(3):291-304.
PMID:
11402439
.
Citations:
23
Fields:
Neo
Neoplasms
Translation:
Humans
Vlastos G, Jean ME, Mirza AN, Mirza NQ,
Kuerer HM
, Ames FC,
Hunt KK
, Ross MI,
Buchholz TA
,
Buzdar AU
, Singletary SE. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol. 2001 Jun; 8(5):425-31.
PMID:
11407517
.
Citations:
31
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Kuerer HM
,
Buzdar AU
, Singletary SE. Biologic basis and evolving role of aromatase inhibitors in the management of invasive carcinoma of the breast. J Surg Oncol. 2001 Jun; 77(2):139-47.
PMID:
11398169
.
Citations:
3
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Copur MS, Ledakis P, Bolton M, Norvell M, Muhvic J. Is anastrozole superior to tamoxifen as first-line therapy for advanced breast cancer? J Clin Oncol. 2001 May 01; 19(9):2578; author reply 2580-2.
PMID:
11331343
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Buchholz TA
, Tucker SL, Erwin J, Mathur D,
Strom EA
, McNeese MD, Hortobagyi GN, Cristofanilli M, Esteva FJ, Newman L, Singletary SE,
Buzdar AU
,
Hunt KK
. Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol. 2001 Apr 15; 19(8):2240-6.
PMID:
11304777
.
Citations:
14
Fields:
Neo
Neoplasms
Translation:
Humans
Newman LA,
Kuerer HM
,
Fornage B
, Mirza N,
Hunt KK
, Ross MI, Ames FC,
Buzdar AU
, Singletary SE. Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer. Am J Surg. 2001 Apr; 181(4):313-8.
PMID:
11438265
.
Citations:
5
Fields:
Gen
General Surgery
Translation:
Humans
Buzdar A
, Dhingra K, Enas N, Ni L, Major M, Melemed A, Seidman A,
Booser D
, Theriault R, Norton L, Hudis C, M?nster PN. Phase I study of a third-generation selective estrogen receptor modulator, LY353381.HCL, in metastatic breast cancer. J Clin Oncol. 2001 Apr 01; 19(7):2002-9.
PMID:
11283133
.
Citations:
9
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Ibrahim NK
,
Buzdar AU
,
Valero V
, Dhingra K, Willey J, Hortobagyi GN. Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma. Cancer. 2001 Feb 15; 91(4):664-71.
PMID:
11241232
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Brito RA,
Valero V
,
Buzdar AU
,
Booser DJ
, Ames F,
Strom E
, Ross M, Theriault RL, Frye D, Kau SW, Asmar L, McNeese M, Singletary SE, Hortobagyi GN. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol. 2001 Feb 01; 19(3):628-33.
PMID:
11157012
.
Citations:
61
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Esteva FJ,
Valero V
, Pusztai L, Boehnke-Michaud L,
Buzdar AU
, Hortobagyi GN. Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist. 2001; 6(2):133-46.
PMID:
11306725
.
Citations:
31
Fields:
Neo
Neoplasms
Translation:
Humans
Ibrahim NK
,
Valero V
, Rahman Z, Theriault RL,
Walters RS
,
Buzdar AU
,
Booser DJ
, Holmes FA, Murray JL, Willey J, Bast R, Hortobagyi GN. Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation. Cancer Invest. 2001; 19(5):459-66.
PMID:
11458813
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Esteva FJ, Hortobagyi GN,
Sahin AA
, Smith TL, Chin DM, Liang SY, Pusztai L,
Buzdar AU
, Bacus SS. Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistry. Pathol Oncol Res. 2001; 7(3):171-7.
PMID:
11692142
.
Citations:
18
Fields:
Neo
Neoplasms
Pat
Pathology
Translation:
Humans
Cells
Michaud LB, Jones KL,
Buzdar AU
. Combination endocrine therapy in the management of breast cancer. Oncologist. 2001; 6(6):538-46.
PMID:
11743215
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
Ibrahim NK
,
Buzdar AU
, Asmar L, Theriault RL, Hortobagyi GN. Doxorubicin-based adjuvant chemotherapy in elderly breast cancer patients: the M.D. Anderson experience, with long-term follow-up. Ann Oncol. 2000 Dec; 11(12):1597-601.
PMID:
11205469
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
Rivera E, Holmes FA, Frye D,
Valero V
, Theriault RL,
Booser D
,
Walters R
,
Buzdar AU
, Dhingra K, Fraschini G, Hortobagyi GN. Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy. Cancer. 2000 Dec 01; 89(11):2195-201.
PMID:
11147589
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Nabholtz JM,
Buzdar A
, Pollak M, Harwin W, Burton G, Mangalik A, Steinberg M, Webster A, von Euler M. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group. J Clin Oncol. 2000 Nov 15; 18(22):3758-67.
PMID:
11078488
.
Citations:
155
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Chang S
, Alderfer JR, Asmar L,
Buzdar AU
. Inflammatory breast cancer survival: the role of obesity and menopausal status at diagnosis. Breast Cancer Res Treat. 2000 Nov; 64(2):157-63.
PMID:
11194451
.
Citations:
18
Fields:
Neo
Neoplasms
Translation:
Humans
Breslin TM,
Cohen L
,
Sahin A
,
Fleming JB
,
Kuerer HM
, Newman LA, Delpassand ES, House R, Ames FC,
Feig BW
, Ross MI, Singletary SE,
Buzdar AU
, Hortobagyi GN,
Hunt KK
. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2000 Oct 15; 18(20):3480-6.
PMID:
11032588
.
Citations:
33
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. Tamoxifen's clinical applications: old and new. Arch Fam Med. 2000 Sep-Oct; 9(9):906-12.
PMID:
11031399
.
Citations:
2
Fields:
Pri
Primary Health Care
Translation:
Humans
Buzdar A
. An overview of the use of non-steroidal aromatase inhibitors in the treatment of breast cancer. Eur J Cancer. 2000 Sep; 36 Suppl 4:S82-4.
PMID:
11056331
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Vlastos G, Rubio IT, Mirza NQ, Newman LA, Aurora R, Alderfer J,
Buzdar AU
, Singletary SE. Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer. Ann Surg Oncol. 2000 Sep; 7(8):581-7.
PMID:
11005556
.
Citations:
18
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Buzdar A
. Exemestane in advanced breast cancer. Anticancer Drugs. 2000 Sep; 11(8):609-16.
PMID:
11081451
.
Citations:
2
Fields:
Ant
Antineoplastic Agents
Translation:
Humans
Katz A,
Strom EA
,
Buchholz TA
, Thames HD, Smith CD,
Jhingran A
, Hortobagyi G,
Buzdar AU
, Theriault R, Singletary SE, McNeese MD. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol. 2000 Aug; 18(15):2817-27.
PMID:
10920129
.
Citations:
90
Fields:
Neo
Neoplasms
Translation:
Humans
Liao Z
,
Strom EA
,
Buzdar AU
, Singletary SE,
Hunt K
, Allen PK, McNeese MD. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. Int J Radiat Oncol Biol Phys. 2000 Jul 15; 47(5):1191-200.
PMID:
10889372
.
Citations:
10
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
PH
Public Health
Meric F, Mirza NQ,
Buzdar AU
,
Hunt KK
, Ames FC, Ross MI, Pollock RE, Newman LA,
Feig BW
,
Strom EA
,
Buchholz TA
, McNeese MD, Hortobagyi GN, Singletary SE. Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer. Ann Surg Oncol. 2000 Jul; 7(6):435-40.
PMID:
10894139
.
Citations:
5
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Newman LA,
Kuerer HM
,
Hunt KK
, Ames FC,
Ross MI
,
Feig BW
, Hortobagyi GN,
Buzdar AU
, Singletary SE. Response to Induction Chemotherapy in Black and White Patients with Locally Advanced Breast Cancer. Breast J. 2000 Jul; 6(4):242-246.
PMID:
11348372
.
Citations:
2
Fields:
Neo
Neoplasms
Patt YZ,
Hassan MM
, Lozano RD, Ellis LM, Peterson JA, Waugh KA. Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide. Am J Clin Oncol. 2000 Jun; 23(3):319-21.
PMID:
10857902
.
Citations:
11
Fields:
Neo
Neoplasms
Translation:
Humans
Vlastos G,
Fornage BD
, Mirza NQ,
Bedi D
, Lenert JT, Winchester DJ, Tolley SM, Ames FC, Ross MI,
Feig BW
,
Hunt KK
,
Buzdar AU
, Singletary SE. The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am J Surg. 2000 Jun; 179(6):446-52.
PMID:
11004328
.
Citations:
8
Fields:
Gen
General Surgery
Translation:
Humans
CT
Clinical Trials
Hoff PM, Valero V,
Buzdar AU
, Singletary SE, Theriault RL,
Booser D
, Asmar L, Frye D, McNeese MD, Hortobagyi GN. Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy. Cancer. 2000 May 01; 88(9):2054-60.
PMID:
10813717
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Ibrahim NK
,
Valero V
, Theriault RL, Willey J,
Walters RS
,
Buzdar AU
,
Booser DJ
, Hortobagyi GN. Phase I study of vinorelbine by 96-hour infusion in advanced metastatic breast cancer. Am J Clin Oncol. 2000 Apr; 23(2):117-21.
PMID:
10776969
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Michaud LB,
Buzdar AU
. Complete estrogen blockade for the treatment of metastatic and early stage breast cancer. Drugs Aging. 2000 Apr; 16(4):261-71.
PMID:
10874521
.
Citations:
1
Fields:
Dru
Drug Therapy
Ger
Geriatrics
Translation:
Humans
Pivot X, Asmar L, Hortobagyi GN, Theriault R, Pastorini F,
Buzdar A
. A retrospective study of first indicators of breast cancer recurrence. Oncology. 2000 Apr; 58(3):185-90.
PMID:
10765118
.
Citations:
19
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Chaudri HA, Trunet PF. Letrozole: which dose to be used? J Clin Oncol. 2000 Apr; 18(8):1802-3.
PMID:
10764444
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Mavligit GM,
Estrov Z
. CA 125: a clinically useful tumor marker in the management of colorectal carcinoma metastatic to the liver in patients with normal carcinoembryonic antigen. Am J Clin Oncol. 2000 Apr; 23(2):213-5.
PMID:
10776987
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Vlastos G, Mirza NQ, Lenert JT,
Hunt KK
, Ames FC,
Feig BW
, Ross MI,
Buzdar AU
, Singletary SE. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy. Cancer. 2000 Mar 15; 88(6):1417-24.
PMID:
10717625
.
Citations:
12
Fields:
Neo
Neoplasms
Translation:
Humans
Hortobagyi GN,
Buzdar AU
, Theriault RL,
Valero V
, Frye D,
Booser DJ
, Holmes FA, Giralt S,
Khouri I
,
Andersson B
, Gajewski JL, Rondon G, Smith TL, Singletary SE, Ames FC, Sneige N,
Strom EA
, McNeese MD, Deisseroth AB,
Champlin RE
. Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. J Natl Cancer Inst. 2000 Feb 02; 92(3):225-33.
PMID:
10655439
.
Citations:
21
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Kushwaha AC
,
Whitman GJ
, Stelling CB, Cristofanilli M,
Buzdar AU
. Primary inflammatory carcinoma of the breast: retrospective review of mammographic findings. AJR Am J Roentgenol. 2000 Feb; 174(2):535-8.
PMID:
10658737
.
Citations:
5
Fields:
Rad
Radiology
Translation:
Humans
Gale RP, Park RE, Dubois R, Bitran JD,
Buzdar A
, Hortobagyi G, Jones SE, Lazar GS, Spitzer G, Swain SM, Vaughn CB, Vogel CE, Martino S. Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancer. Clin Transplant. 2000 Feb; 14(1):32-41.
PMID:
10693633
.
Citations:
9
Fields:
Tra
Transplantation
Translation:
Humans
Pivot X, Asmar L,
Buzdar AU
,
Valero V
, Hortobagyi G. A unified definition of clinical anthracycline resistance breast cancer. Br J Cancer. 2000 Feb; 82(3):529-34.
PMID:
10682660
; PMCID:
PMC2363337
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
Ibrahim NK
,
Sahin AA
, Dubrow RA,
Lynch PM
, Boehnke-Michaud L,
Valero V
,
Buzdar AU
, Hortobagyi GN. Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer. Lancet. 2000 Jan 22; 355(9200):281-3.
PMID:
10675076
.
Citations:
29
Fields:
Med
Medicine (General)
Translation:
Humans
CT
Clinical Trials
Lenert JT, Vlastos G, Mirza NQ, Winchester DJ, Binkley SM, Ames FC, Ross MI,
Feig BW
,
Hunt KK
,
Strom E
,
Buzdar AU
, Hortobagyi GN, Singletary SE. Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients. Ann Surg Oncol. 1999 Dec; 6(8):762-7.
PMID:
10622504
.
Citations:
5
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. Critique of survival update analysis from two phase III anastrozole clinical trials. Ann Surg Oncol. 1999 Dec; 6(8 Suppl):8S-11S.
PMID:
10619453
.
Citations:
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Bland KI,
Buzdar AU
. Safety and tolerability of endocrine therapies used in the treatment of advanced breast cancer. Ann Surg Oncol. 1999 Dec; 6(8 Suppl):12S-13S.
PMID:
10619454
.
Citations:
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Robertson JF, Howell A,
Buzdar A
, von Euler M, Lee D. Static disease on anastrozole provides similar benefit as objective response in patients with advanced breast cancer. Breast Cancer Res Treat. 1999 Nov; 58(2):157-62.
PMID:
10674881
.
Citations:
8
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
, Singletary SE, Theriault RL,
Booser DJ
,
Valero V
,
Ibrahim N
, Smith TL, Asmar L, Frye D, Manuel N, Kau SW, McNeese M,
Strom E
,
Hunt K
, Ames F, Hortobagyi GN. Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. J Clin Oncol. 1999 Nov; 17(11):3412-7.
PMID:
10550135
.
Citations:
33
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Michaud LB,
Buzdar AU
. Risks and benefits of aromatase inhibitors in postmenopausal breast cancer. Drug Saf. 1999 Oct; 21(4):297-309.
PMID:
10514021
.
Citations:
6
Fields:
Dru
Drug Therapy
Tox
Toxicology
Translation:
Humans
Ibrahim NK
, Rahman Z,
Valero V
, Willey J, Theriault RL,
Buzdar AU
, Murray JL, Bast R, Hortobagyi GN. Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma. Cancer. 1999 Oct 01; 86(7):1251-7.
PMID:
10506711
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
, Hortobagyi GN. Recent advances in adjuvant therapy of breast cancer. Semin Oncol. 1999 Aug; 26(4 Suppl 12):21-7.
PMID:
10482191
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Hortobagyi GN, Hung MC,
Buzdar AU
. Recent developments in breast cancer therapy. Semin Oncol. 1999 Aug; 26(4 Suppl 12):11-20.
PMID:
10482190
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Kuerer HM
,
Sahin AA
,
Hunt KK
, Newman LA, Breslin TM, Ames FC, Ross MI,
Buzdar AU
, Hortobagyi GN, Singletary SE. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999 Jul; 230(1):72-8.
PMID:
10400039
; PMCID:
PMC1420847
.
Citations:
78
Fields:
Gen
General Surgery
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. Role of aromatase inhibitors in advanced breast cancer. Endocr Relat Cancer. 1999 Jun; 6(2):219-25.
PMID:
10731112
.
Citations:
4
Fields:
End
Endocrinology
Neo
Neoplasms
Translation:
Humans
Valero V
,
Buzdar AU
, Theriault RL, Azarnia N, Fonseca GA, Willey J, Ewer M,
Walters RS
, Mackay B, Podoloff D,
Booser D
, Lee LW, Hortobagyi GN. Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer. J Clin Oncol. 1999 May; 17(5):1425-34.
PMID:
10334527
.
Citations:
12
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buchholz TA
,
Hunt KK
, Amosson CM, Tucker SL,
Strom EA
, McNeese MD,
Buzdar AU
, Singletary SE, Hortobagyi GN. Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am. 1999 May-Jun; 5(3):159-64.
PMID:
10367172
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Knoche AJ, Michaud LB,
Buzdar AU
. Efficacy of Anastrozole in a Consecutive Series of Advanced Breast Cancer Patients Treated with Multiple Prior Chemotherapies and Endocrine Agents: M. D. Anderson Cancer Center Experience. Breast J. 1999 May; 5(3):176-181.
PMID:
11348281
.
Citations:
1
Fields:
Neo
Neoplasms
Cristofanilli M, Holmes FA, Esparza L,
Valero V
,
Buzdar AU
, Neidhart JA, Hortobagyi GN. Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience. Breast Cancer Res Treat. 1999 Apr; 54(3):225-33.
PMID:
10445421
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Holmes FA,
Valero V
,
Walters RS
, Theriault RL,
Booser DJ
, Gibbs H, Fraschini G,
Buzdar AU
, Willey J, Frye D, Asmar L, Hortobagyi GN. Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results. Ann Oncol. 1999 Apr; 10(4):403-11.
PMID:
10370782
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Berry DL, Theriault RL, Holmes FA, Parisi VM,
Booser DJ
, Singletary SE,
Buzdar AU
, Hortobagyi GN. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol. 1999 Mar; 17(3):855-61.
PMID:
10071276
.
Citations:
44
Fields:
Neo
Neoplasms
Translation:
Humans
Kuerer HM
, Newman LA, Smith TL, Ames FC,
Hunt KK
, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N,
Buchholz TA
, Ross MI, McNeese MD,
Buzdar AU
, Hortobagyi GN, Singletary SE. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol. 1999 Feb; 17(2):460-9.
PMID:
10080586
.
Citations:
348
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Blum JL, Jones SE,
Buzdar AU
, LoRusso PM, Kuter I, Vogel C, Osterwalder B, Burger HU, Brown CS, Griffin T. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol. 1999 Feb; 17(2):485-93.
PMID:
10080589
.
Citations:
143
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Ibrahim NK
, Hortobagyi GN, Ewer M, Ali MK, Asmar L, Theriault RL, Fraschini G, Frye DK,
Buzdar AU
. Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience. Cancer Chemother Pharmacol. 1999; 43(6):471-8.
PMID:
10321507
.
Citations:
8
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Hortobagyi GN. Breast cancer. Cancer Chemother Biol Response Modif. 1999; 18:435-69.
PMID:
10800497
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Rahman ZU, Frye DK, Smith TL, Asmar L, Theriault RL,
Buzdar AU
, Hortobagyi GN. Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference. Cancer. 1999 Jan 01; 85(1):104-11.
PMID:
9921981
.
Citations:
25
Fields:
Neo
Neoplasms
Translation:
Humans
Kuerer HM
, Newman LA,
Buzdar AU
,
Hunt KK
, Dhingra K,
Buchholz TA
, Binkley SM, Ames FC,
Feig BW
, Ross MI, Hortobagyi GN, Singletary SE. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg. 1998 Dec; 176(6):502-9.
PMID:
9926779
.
Citations:
29
Fields:
Gen
General Surgery
Translation:
Humans
CT
Clinical Trials
Chang S
,
Buzdar AU
, Hursting SD. Inflammatory breast cancer and body mass index. J Clin Oncol. 1998 Dec; 16(12):3731-5.
PMID:
9850015
.
Citations:
37
Fields:
Neo
Neoplasms
Translation:
Humans
Kuerer HM
, Newman LA,
Fornage BD
, Dhingra K,
Hunt KK
,
Buzdar AU
, Ames FC, Ross MI,
Feig BW
, Hortobagyi GN, Singletary SE. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 1998 Dec; 5(8):673-80.
PMID:
9869512
.
Citations:
11
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Jonat W, Howell A, Jones SE, Blomqvist CP, Vogel CL, Eiermann W, Wolter JM, Steinberg M, Webster A, Lee D. Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group. Cancer. 1998 Sep 15; 83(6):1142-52.
PMID:
9740079
.
Citations:
65
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar A
. The place of chemotherapy in the treatment of early breast cancer. Br J Cancer. 1998 Sep; 78 Suppl 4:16-20.
PMID:
9741784
; PMCID:
PMC2062752
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Rahman ZU, Hortobagyi GN,
Buzdar AU
,
Champlin R
. High-dose chemotherapy with autologous stem cell support in patients with breast cancer. Cancer Treat Rev. 1998 Aug; 24(4):249-63.
PMID:
9805506
.
Citations:
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
Kuerer HM
, Newman LA,
Buzdar AU
, Dhingra K,
Hunt KK
,
Buchholz TA
, Binkley SM,
Strom EA
, Ames FC, Ross MI,
Feig BW
, McNeese MD, Hortobagyi GN, Singletary SE. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. Cancer J Sci Am. 1998 Jul-Aug; 4(4):230-6.
PMID:
9689981
.
Citations:
18
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Chang S
, Parker SL, Pham T,
Buzdar AU
, Hursting SD. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992. Cancer. 1998 Jun 15; 82(12):2366-72.
PMID:
9635529
.
Citations:
69
Fields:
Neo
Neoplasms
Translation:
Humans
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 1998 May 16; 351(9114):1451-67.
PMID:
9605801
.
Citations:
778
Fields:
Med
Medicine (General)
Translation:
Humans
Williams GM. Differences in toxicity findings for antiestrogens. J Clin Oncol. 1998 May; 16(5):1999-2000.
PMID:
9586922
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Diaz-Canton EA,
Valero V
, Rahman Z, Rodriguez-Monge E, Frye D, Smith T,
Buzdar AU
, Hortobagyi GN. Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texas M.D. Anderson Cancer Center experience and review of the literature. Ann Oncol. 1998 Apr; 9(4):413-8.
PMID:
9636832
.
Citations:
10
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Anastrozole: a new addition to the armamentarium against advanced breast cancer. Am J Clin Oncol. 1998 Apr; 21(2):161-6.
PMID:
9537204
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Adkins DR, Brown RA, DiPersio JF. Patient selection in high-dose trials of breast cancer. J Clin Oncol. 1998 Mar; 16(3):1238-9.
PMID:
9508217
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Hortobagyi G. Update on endocrine therapy for breast cancer. Clin Cancer Res. 1998 Mar; 4(3):527-34.
PMID:
9533518
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
Hortobagyi GN,
Buzdar AU
. Anastrozole (Arimidex), a new aromatase inhibitor for advanced breast cancer: mechanism of action and role in management. Cancer Invest. 1998; 16(6):385-90.
PMID:
9679529
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Hortobagyi GN. Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy. J Clin Oncol. 1998 Jan; 16(1):348-53.
PMID:
9440763
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
Animals
Kinney AY,
Sahin A
, Vernon SW, Frankowski RF, Annegers JF, Hortobagyi GN,
Buzdar AU
, Frye DK, Dhingra K. The prognostic significance of sialyl-Tn antigen in women treated with breast carcinoma treated with adjuvant chemotherapy. Cancer. 1997 Dec 15; 80(12):2240-9.
PMID:
9404700
.
Citations:
15
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Roseman BJ,
Buzdar AU
, Singletary SE. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer. J Surg Oncol. 1997 Nov; 66(3):215-20.
PMID:
9369969
.
Citations:
2
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Hortobagyi GN, Willey J, Rahman Z, Holmes FA, Theriault RL,
Buzdar AU
. Prospective assessment of cardiac toxicity during a randomized phase II trial of doxorubicin and paclitaxel in metastatic breast cancer. Semin Oncol. 1997 Oct; 24(5 Suppl 17):S17-65-S17-68.
PMID:
9374097
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Rahman ZU, Frye DK,
Buzdar AU
, Smith TL, Asmar L,
Champlin RE
, Hortobagyi GN. Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer. J Clin Oncol. 1997 Oct; 15(10):3171-7.
PMID:
9336352
.
Citations:
8
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Hortobagyi GN, Asmar L, Theriault RL, Rahman Z, McNeese M, Singletary S, Ames F. Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer. Semin Oncol. 1997 Oct; 24(5 Suppl 17):S17-31-S17-34.
PMID:
9374089
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Inoue T, Kim EE, Wallace S, Yang DJ,
Wong FC
, Bassa P,
Buzdar AU
, Podoloff DA. Preliminary study of cardiac accumulation of F-18 fluorotamoxifen in patients with breast cancer. Clin Imaging. 1997 Sep-Oct; 21(5):332-6.
PMID:
9316752
.
Citations:
2
Fields:
Dia
Diagnostic Imaging
Translation:
Humans
Fleming RY, Asmar L,
Buzdar AU
, McNeese MD, Ames FC, Ross MI, Singletary SE. Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma. Ann Surg Oncol. 1997 Sep; 4(6):452-61.
PMID:
9309333
.
Citations:
20
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Herrada J,
Iyer RB
, Atkinson EN, Sneige N,
Buzdar AU
, Hortobagyi GN. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res. 1997 Sep; 3(9):1565-9.
PMID:
9815844
.
Citations:
35
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Asmar L, Hortobagyi GN. Impact of patient characteristics on treatment outcome: anthracycline resistance. Eur J Cancer. 1997 Aug; 33 Suppl 7:S3-6.
PMID:
9486095
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Hortobagyi GN, Holmes FA, Theriault RL, Rahman Z,
Buzdar AU
. Combination chemotherapy with paclitaxel and doxorubicin for metastatic breast cancer. Semin Oncol. 1997 Aug; 24(4 Suppl 11):S11-13-S11-19.
PMID:
9314293
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
, Jonat W, Howell A, Plourde PV. ARIMIDEX: a potent and selective aromatase inhibitor for the treatment of advanced breast cancer. J Steroid Biochem Mol Biol. 1997 Apr; 61(3-6):145-9.
PMID:
9365184
.
Citations:
5
Fields:
Bio
Biochemistry
Mol
Molecular Biology
Translation:
Humans
Buzdar AU
, Jones SE, Vogel CL, Wolter J, Plourde P, Webster A. A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group. Cancer. 1997 Feb 15; 79(4):730-9.
PMID:
9024711
.
Citations:
38
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Hortobagyi GN, Holmes FA,
Ibrahim N
,
Champlin R
,
Buzdar AU
. The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer. Semin Oncol. 1997 Feb; 24(1 Suppl 3):S30-3.
PMID:
9071338
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Ueno NT
,
Buzdar AU
, Singletary SE, Ames FC, McNeese MD, Holmes FA, Theriault RL,
Strom EA
, Wasaff BJ, Asmar L, Frye D, Hortobagyi GN. Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center. Cancer Chemother Pharmacol. 1997; 40(4):321-9.
PMID:
9225950
.
Citations:
66
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
Holmes FA, Madden T, Newman RA,
Valero V
, Theriault RL, Fraschini G,
Walters RS
,
Booser DJ
,
Buzdar AU
, Willey J, Hortobagyi GN. Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer. J Clin Oncol. 1996 Oct; 14(10):2713-21.
PMID:
8874332
.
Citations:
21
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Diamandidou E,
Buzdar AU
, Smith TL, Frye D, Witjaksono M, Hortobagyi GN. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol. 1996 Oct; 14(10):2722-30.
PMID:
8874333
.
Citations:
19
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Plourde PV, Hortobagyi GN. Aromatase inhibitors in metastatic breast cancer. Semin Oncol. 1996 Aug; 23(4 Suppl 9):28-32.
PMID:
8824462
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK,
Buzdar AU
. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol. 1996 Aug; 14(8):2197-205.
PMID:
8708708
.
Citations:
159
Fields:
Neo
Neoplasms
Translation:
Humans
Inoue T, Kim EE, Wallace S, Yang DJ,
Wong FC
, Bassa P, Cherif A, Delpassand E,
Buzdar A
, Podoloff DA. Positron emission tomography using [18F]fluorotamoxifen to evaluate therapeutic responses in patients with breast cancer: preliminary study. Cancer Biother Radiopharm. 1996 Aug; 11(4):235-45.
PMID:
10851543
.
Citations:
12
Fields:
Neo
Neoplasms
Pha
Pharmacology
Rad
Radiotherapy
The
Therapeutics
Translation:
Humans
Buzdar A
, Jonat W, Howell A, Jones SE, Blomqvist C, Vogel CL, Eiermann W, Wolter JM, Azab M, Webster A, Plourde PV. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol. 1996 Jul; 14(7):2000-11.
PMID:
8683230
.
Citations:
59
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
, Smith R, Vogel C, Bonomi P, Keller AM, Favis G, Mulagha M, Cooper J. Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials. Cancer. 1996 Jun 15; 77(12):2503-13.
PMID:
8640699
.
Citations:
12
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Bassa P, Kim EE, Inoue T,
Wong FC
, Korkmaz M, Yang DJ,
Wong WH
, Hicks KW,
Buzdar AU
, Podoloff DA. Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer. J Nucl Med. 1996 Jun; 37(6):931-8.
PMID:
8683314
.
Citations:
25
Fields:
Nuc
Nuclear Medicine
Translation:
Humans
Payne JY, Holmes F, Cohen PR,
Gagel R
,
Buzdar A
, Dhingra K. Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia. South Med J. 1996 May; 89(5):542-5.
PMID:
8638189
.
Citations:
7
Fields:
Med
Medicine (General)
Translation:
Humans
Ibrahim NK
, Frye DK,
Buzdar AU
,
Walters RS
, Hortobagyi GN. Doxorubicin-based chemotherapy in elderly patients with metastatic breast cancer. Tolerance and outcome. Arch Intern Med. 1996 Apr 22; 156(8):882-8.
PMID:
8774207
.
Citations:
9
Fields:
Int
Internal Medicine
Translation:
Humans
Hunt KK
, Ames FC, Singletary SE,
Buzdar AU
, Hortobagyi GN. Locally advanced noninflammatory breast cancer. Surg Clin North Am. 1996 Apr; 76(2):393-410.
PMID:
8610271
.
Citations:
5
Fields:
Gen
General Surgery
Translation:
Humans
Mora EM, Singletary SE,
Buzdar AU
, Johnston DA. Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients. Ann Surg Oncol. 1996 Mar; 3(2):162-8.
PMID:
8646517
.
Citations:
3
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Valero V
, Holmes FA,
Walters RS
, Theriault RL, Esparza L, Fraschini G, Fonseca GA, Bellet RE,
Buzdar AU
, Hortobagyi GN. Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer. J Clin Oncol. 1995 Dec; 13(12):2886-94.
PMID:
8523051
.
Citations:
47
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
, Singletary SE,
Booser DJ
, Frye DK, Wasaff B, Hortobagyi GN. Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience. Surg Oncol Clin N Am. 1995 Oct; 4(4):715-34.
PMID:
8535907
.
Citations:
19
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Ibrahim NK
,
Buzdar AU
. Aromatase inhibitors: current status. Am J Clin Oncol. 1995 Oct; 18(5):407-17.
PMID:
7572758
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Animals
Dhingra K, Fritsche H, Murray JL, LoBuglio AF, Khazaeli MB, Kelley S, Tepper MA, Grasela D,
Buzdar A
,
Valero V
, et al. Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin. Cancer Res. 1995 Jul 15; 55(14):3060-7.
PMID:
7606728
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Dhingra K, Frye D, Newman RA,
Walters R
, Theriault R, Fraschini G, Smith T,
Buzdar A
, Hortobagyi GN. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer. Clin Cancer Res. 1995 Jul; 1(7):691-7.
PMID:
9816034
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Hortobagyi GN,
Buzdar AU
. Current status of adjuvant systemic therapy for primary breast cancer: progress and controversy. CA Cancer J Clin. 1995 Jul-Aug; 45(4):199-226.
PMID:
7600278
.
Citations:
11
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Holmes FA, Hortobagyi GN. Paclitaxel in the treatment of metastatic breast cancer: M.D. Anderson Cancer Center experience. Semin Oncol. 1995 Jun; 22(3 Suppl 6):101-4.
PMID:
7541151
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Hortobagyi GN,
Buzdar AU
,
Strom EA
, Ames FC, Singletary SE. Primary chemotherapy for early and advanced breast cancer. Cancer Lett. 1995 Mar 23; 90(1):103-9.
PMID:
7720036
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Jaiyesimi IA,
Buzdar AU
, Decker DA, Hortobagyi GN. Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol. 1995 Feb; 13(2):513-29.
PMID:
7844613
.
Citations:
85
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Esparza L, Natale R, Cody R, Calzone K, Benson AB, Sheehan T, Berry W. Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study. Am J Clin Oncol. 1994 Oct; 17(5):417-21.
PMID:
8092114
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Hortobagyi GN, Holmes FA, Theriault RL,
Buzdar AU
. Use of Taxol (paclitaxel) in breast cancer. Oncology. 1994 Oct; 51 Suppl 1:29-32.
PMID:
7970507
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
Mondzac AM. Tamoxifen dosage and bioequivalence: a correction. J Clin Oncol. 1994 Sep; 12(9):1993-4.
PMID:
8083720
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Dunphy FR, Spitzer G, Fornoff JE, Yau JC, Huan SD, Dicke KA,
Buzdar AU
, Hortobagyi GN. Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support. Cancer. 1994 Apr 15; 73(8):2157-67.
PMID:
8156520
.
Citations:
10
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Dhingra K,
Valero V
, Gutierrez L, Theriault R,
Booser D
, Holmes F,
Buzdar A
, Fraschini G, Hortobagyi G. Phase II study of deoxyspergualin in metastatic breast cancer. Invest New Drugs. 1994; 12(3):235-41.
PMID:
7896543
.
Citations:
8
Fields:
Ant
Antineoplastic Agents
Pha
Pharmacology
Translation:
Humans
CT
Clinical Trials
Yang DJ,
Li C
, Kuang LR, Price JE,
Buzdar AU
, Tansey W, Cherif A, Gretzer M, Kim EE, Wallace S. Imaging, biodistribution and therapy potential of halogenated tamoxifen analogues. Life Sci. 1994; 55(1):53-67.
PMID:
8015349
.
Citations:
9
Fields:
Bio
Biochemistry
Bio
Biology
Phy
Physiology
Translation:
Humans
Animals
Cells
Buzdar AU
, Kau S, Hortobagyi GN, Theriault RL,
Booser D
, Holmes FA,
Walters R
, Krakoff IH. Phase I trial of droloxifene in patients with metastatic breast cancer. Cancer Chemother Pharmacol. 1994; 33(4):313-6.
PMID:
8281625
.
Citations:
4
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Singletary SE, Ames FC,
Buzdar AU
. Management of inflammatory breast cancer. World J Surg. 1994 Jan-Feb; 18(1):87-92.
PMID:
8197782
.
Citations:
3
Fields:
Gen
General Surgery
Translation:
Humans
Buzdar AU
, Hortobagyi GN, Frye D, Ho D,
Booser DJ
,
Valero V
, Holmes FA, Birmingham BK, Bui K, Yeh C, et al. Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer. J Clin Oncol. 1994 Jan; 12(1):50-4.
PMID:
8270984
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Dhingra K, Fritsche H, Murray JL, LoBuglio AF, Khazaeli MB, Kelley S, Tepper M, Greene D,
Booser D
,
Buzdar A
, et al. Suppression of human anti-mouse antibody response to murine monoclonal antibody L6 by deoxyspergualin: a phase I study. Adv Exp Med Biol. 1994; 353:193-202.
PMID:
7985538
.
Citations:
1
Fields:
Bio
Biology
Med
Medicine (General)
Translation:
Humans
Animals
CT
Clinical Trials
Bastarrachea J, Hortobagyi GN, Smith TL, Kau SW,
Buzdar AU
. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med. 1994 Jan 01; 120(1):18-25.
PMID:
8250452
.
Citations:
37
Fields:
Int
Internal Medicine
Translation:
Humans
Buzdar AU
, Kau SW, Smith TL, Ames F, Singletary E,
Strom E
, McNeese M, Hortobagyi GN. The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer. Cancer. 1993 Jun 01; 71(11):3680-4.
PMID:
8490917
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
LeBlond RF. Carcinoma of the male breast. Ann Intern Med. 1993 May 01; 118(9):749.
PMID:
8460868
.
Citations:
Fields:
Int
Internal Medicine
Translation:
Humans
Cohen PR,
Buzdar AU
. Metastatic breast carcinoma mimicking an acute paronychia of the great toe: case report and review of subungual metastases. Am J Clin Oncol. 1993 Feb; 16(1):86-91.
PMID:
8424412
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Holmes FA,
Valero V
,
Walters RS
, Theriault RL,
Booser DJ
, Fraschini G,
Buzdar AU
, Frye D, Gibbs HR, Hortobagyi GN. The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancer. J Natl Cancer Inst Monogr. 1993; (15):161-9.
PMID:
7912522
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
, Hortob?gyi GN. Present status of anthracyclines in the adjuvant treatment of breast cancer. Drugs. 1993; 45 Suppl 2:10-9; discussion 18-9.
PMID:
7693417
.
Citations:
9
Fields:
Dru
Drug Therapy
Pha
Pharmacology
Translation:
Humans
Theriault RL, Stallings CB,
Buzdar AU
. Pregnancy and breast cancer: clinical and legal issues. Am J Clin Oncol. 1992 Dec; 15(6):535-9.
PMID:
1333169
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Jaiyesimi IA,
Buzdar AU
,
Sahin AA
,
Ross MA
. Carcinoma of the male breast. Ann Intern Med. 1992 Nov 01; 117(9):771-7.
PMID:
1416579
.
Citations:
13
Fields:
Int
Internal Medicine
Translation:
Humans
Buzdar AU
, Hortobagyi GN, Kau SW, Smith TL, Fraschini G, Holmes FA, Gutterman JU, Hug VM, Singletary SE, Ames FC, et al. Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer. J Clin Oncol. 1992 Oct; 10(10):1540-6.
PMID:
1403033
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Voravud N,
el-Naggar AK
,
Balch CM
, Theriault RL. Metastatic lobular breast carcinoma simulating primary colon cancer. Am J Clin Oncol. 1992 Aug; 15(4):365-9.
PMID:
1514536
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Vassilopoulou-Sellin R, Cangir A, Samaan NA. Acanthosis nigricans and severe insulin resistance in an adolescent girl with thyroid cancer: clinical response to antineoplastic therapy. Am J Clin Oncol. 1992 Jun; 15(3):273-6.
PMID:
1590285
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Jaiyesimi IA,
Buzdar AU
, Hortobagyi G. Inflammatory breast cancer: a review. J Clin Oncol. 1992 Jun; 10(6):1014-24.
PMID:
1588366
.
Citations:
78
Fields:
Neo
Neoplasms
Translation:
Humans
Jaiyesimi IA,
Buzdar AU
. Adjuvant chemotherapy in high-risk breast cancer patients with ten or more positive lymph nodes. Am J Clin Oncol. 1992 Apr; 15(2):180-3.
PMID:
1313203
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Kau SW, Hortobagyi GN, Ames FC, Holmes FA, Fraschini G, Hug V, Theriault RL, McNeese MD, Singletary SE. Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy. Cancer. 1992 Jan 15; 69(2):448-52.
PMID:
1728373
.
Citations:
11
Fields:
Neo
Neoplasms
Translation:
Humans
Walters RS
, Frye D,
Buzdar AU
, Holmes FA, Hortobagyi GN. A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma. Cancer. 1992 Jan 15; 69(2):476-81.
PMID:
1728377
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Simmons JR,
Buzdar AU
, Ota DM, Marts K, Hortobagyi GN. Complications associated with indwelling catheters. Med Pediatr Oncol. 1992; 20(1):22-5.
PMID:
1727207
.
Citations:
1
Fields:
Neo
Neoplasms
Ped
Pediatrics
Translation:
Humans
Holmes FA,
Walters RS
, Theriault RL, Forman AD, Newton LK, Raber MN,
Buzdar AU
, Frye DK, Hortobagyi GN. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst. 1991 Dec 18; 83(24):1797-805.
PMID:
1683908
.
Citations:
141
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Fraschini G, Holmes FA, Esparza L, Theriault RL,
Buzdar AU
, Hortobagyi GN. Phase I-II study of high-dose etoposide in patients with refractory breast cancer. Invest New Drugs. 1991 Nov; 9(4):365-7.
PMID:
1804815
.
Citations:
1
Fields:
Ant
Antineoplastic Agents
Pha
Pharmacology
Translation:
Humans
CT
Clinical Trials
Macheledt JE,
Buzdar AU
, Hortobagyi GN, Frye DK, Gutterman JU, Holmes FA. Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer. Breast Cancer Res Treat. 1991 Aug; 18(3):165-70.
PMID:
1756259
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Lamki LM,
Buzdar AU
, Singletary SE, Rosenblum MG, Bhadkamkar V, Esparza L, Podoloff DA, Zukiwski A, Hortobagyi GN, Murray JL. Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study. J Nucl Med. 1991 Jul; 32(7):1326-32.
PMID:
2066785
.
Citations:
12
Fields:
Nuc
Nuclear Medicine
Translation:
Humans
Ziegler LD,
Buzdar AU
. Recent advances in the treatment of breast cancer. Am J Med Sci. 1991 May; 301(5):337-52.
PMID:
2021157
.
Citations:
Fields:
Med
Medicine (General)
Translation:
Humans
Ziegler LD,
Buzdar AU
. Current status of adjuvant therapy of early breast cancer. Am J Clin Oncol. 1991 Apr; 14(2):101-10.
PMID:
2028918
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Wallerstein R, Spitzer G, Dunphy F, Huan S, Hortobagyi G, Yau J,
Buzdar A
, Holmes F, Theriault R, Ewer M, et al. A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer. J Clin Oncol. 1990 Nov; 8(11):1782-8.
PMID:
2121909
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Hortobagyi GN. Sixteen-week, dose-intense chemotherapy in adjuvant treatment of breast cancer. J Natl Cancer Inst. 1990 Jul 18; 82(14):1220-1.
PMID:
2362293
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Dunphy FR, Spitzer G,
Buzdar AU
, Hortobagyi GN, Horwitz LJ, Yau JC, Spinolo JA, Jagannath S, Holmes F, Wallerstein RO, et al. Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J Clin Oncol. 1990 Jul; 8(7):1207-16.
PMID:
2358837
.
Citations:
19
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Holmes FA, Fritsche HA, Loewy JW, Geitner AM, Sutton RC,
Buzdar AU
, Hortobagyi GN. Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay. J Clin Oncol. 1990 Jun; 8(6):1025-35.
PMID:
2189952
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Sutton R,
Buzdar AU
, Hortobagyi GN. Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients. Cancer. 1990 Feb 15; 65(4):847-50.
PMID:
2297653
.
Citations:
19
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, McNeese MD, Hortobagyi GN, Smith TL, Kau S, Fraschini G, Hug V, Ellerbroek N, Holmes FA, Ames F, et al. Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer? Cancer. 1990 Feb 01; 65(3):394-9.
PMID:
2297630
.
Citations:
9
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
. Current status of endocrine treatment of carcinoma of the breast. Semin Surg Oncol. 1990; 6(2):77-82.
PMID:
2180045
.
Citations:
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Hortobagyi GN, Theriault RL, Frye D,
Walters RS
, Fraschini G, Tashima CK, Ro JS, Salewski E,
Buzdar AU
. Pirarubicin in combination chemotherapy for metastatic breast cancer. Am J Clin Oncol. 1990; 13 Suppl 1:S54-6.
PMID:
2291460
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Theriault RL,
Buzdar AU
. Acute superior vena caval thrombosis after central venous catheter removal: successful treatment with thrombolytic therapy. Med Pediatr Oncol. 1990; 18(1):77-80.
PMID:
2152960
.
Citations:
2
Fields:
Neo
Neoplasms
Ped
Pediatrics
Translation:
Humans
Hortobagyi GN, Dunphy F,
Buzdar AU
, Spitzer G. Dose intensity studies in breast cancer--autologous bone marrow transplantation. Prog Clin Biol Res. 1990; 354B:195-209.
PMID:
2236166
.
Citations:
Fields:
Bio
Biology
Med
Medicine (General)
Translation:
Humans
Koh EH,
Buzdar AU
, Ames FC, Singletary SE, McNeese MD, Frye D, Holmes FA, Fraschini G, Hug V, Theriault RL, et al. Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience. Cancer Chemother Pharmacol. 1990; 27(2):94-100.
PMID:
2249339
.
Citations:
4
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Hortobagyi GN, Esparza LT, Holmes FA, Ro JS, Fraschini G, Lichtiger B. Elliptinium acetate in metastatic breast cancer--a phase II study. Oncology. 1990; 47(2):101-4.
PMID:
2314820
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Vanek N, Hortobagyi GN,
Buzdar AU
. Radiotherapy enhances the toxicity of aminoglutethimide. Med Pediatr Oncol. 1990; 18(2):162-4.
PMID:
2154663
.
Citations:
Fields:
Neo
Neoplasms
Ped
Pediatrics
Translation:
Humans
Ang PT,
Buzdar AU
, Smith TL, Kau S, Hortobagyi GN. Analysis of dose intensity in doxorubicin-containing adjuvant chemotherapy in stage II and III breast carcinoma. J Clin Oncol. 1989 Nov; 7(11):1677-84.
PMID:
2809682
.
Citations:
8
Fields:
Neo
Neoplasms
Translation:
Humans
Patel HZ,
Buzdar AU
, Hortobagyi GN. Role of adjuvant chemotherapy in male breast cancer. Cancer. 1989 Oct 15; 64(8):1583-5.
PMID:
2676137
.
Citations:
21
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Thoms WW, McNeese MD, Fletcher GH,
Buzdar AU
, Singletary SE, Oswald MJ. Multimodal treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):739-45.
PMID:
2487034
.
Citations:
13
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
Hortobagyi GN, Hug V,
Buzdar AU
, Kau SW, Holmes FA, Fritsche HA. Sequential cyclic combined hormonal therapy for metastatic breast cancer. Cancer. 1989 Sep 01; 64(5):1002-6.
PMID:
2527085
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Merkel DE,
Fuqua SA
, Tandon AK, Hill SM,
Buzdar AU
, McGuire WL. Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J Clin Oncol. 1989 Aug; 7(8):1129-36.
PMID:
2569033
.
Citations:
17
Fields:
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Buzdar AU
, Kau SW, Smith TL, Hortobagyi GN. Ten-year results of FAC adjuvant chemotherapy trial in breast cancer. Am J Clin Oncol. 1989 Apr; 12(2):123-8.
PMID:
2705401
.
Citations:
9
Fields:
Neo
Neoplasms
Translation:
Humans
Theriault RL, Hortobagyi GN, Fritsche HA, Frye D, Martinez R,
Buzdar AU
. The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy. Cancer. 1989 Mar 01; 63(5):828-35.
PMID:
2914290
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Chu PS,
Buzdar AU
, Hortobagyi GN. Trilostane with hydrocortisone in treatment of metastatic breast cancer. Breast Cancer Res Treat. 1989 Mar; 13(2):117-21.
PMID:
2659103
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Hortobagyi GN, Frye D,
Buzdar AU
, Ewer MS, Fraschini G, Hug V, Ames F, Montague E, Carrasco CH, Mackay B, et al. Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma. Cancer. 1989 Jan 01; 63(1):37-45.
PMID:
2910423
.
Citations:
35
Fields:
Neo
Neoplasms
Translation:
Humans
McCready DR, Hortobagyi GN, Kau SW, Smith TL,
Buzdar AU
,
Balch CM
. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg. 1989 Jan; 124(1):21-5.
PMID:
2910244
.
Citations:
27
Fields:
Gen
General Surgery
Translation:
Humans
Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. N Engl J Med. 1988 12 29; 319(26):1681-92.
PMID:
3205265
.
Citations:
142
Fields:
Med
Medicine (General)
Translation:
Humans
Hortobagyi GN, Ames FC,
Buzdar AU
, Kau SW, McNeese MD, Paulus D, Hug V, Holmes FA, Romsdahl MM, Fraschini G, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer. 1988 Dec 15; 62(12):2507-16.
PMID:
3056604
.
Citations:
74
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Hortobagyi GN, Smith TL, Kau S, Marcus C, Holmes FA, Hug V, Fraschini G, Ames FC, Martin RG. Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs. Cancer. 1988 Nov 15; 62(10):2098-104.
PMID:
3179922
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Theriault RL, Hortobagyi GN, Kau SW, Holmes FA, Hug V, Fraschini G, Jabboury K,
Buzdar AU
. Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer. Cancer. 1988 Nov 15; 62(10):2105-10.
PMID:
3179923
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Hortobagyi GN,
Buzdar AU
. Management of locally advanced breast cancer. Am J Clin Oncol. 1988 Oct; 11(5):597-601.
PMID:
2845771
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Fraschini G, Holmes FA,
Buzdar AU
, Hug V, Hortobagyi GN. Cisplatin in combination with continuous infusion vinblastine for refractory breast cancer. Am J Clin Oncol. 1988 Aug; 11(4):448-50.
PMID:
3407623
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Skinner WL,
Buzdar AU
, Libshitz HI. Massive osteolysis of the right clavicle developing after radiation therapy. JAMA. 1988 Jul 15; 260(3):375-6.
PMID:
3379746
.
Citations:
Fields:
Med
Medicine (General)
Translation:
Humans
PH
Public Health
Buzdar AU
. Chemotherapeutic approaches to advanced breast cancer. Semin Oncol. 1988 Jun; 15(3 Suppl 4):65-70.
PMID:
3293220
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Smith TL, Hortobagyi GN, Bert? E. Bilateral primary breast cancer in patients treated with adjuvant therapy. Am J Clin Oncol. 1988 Apr; 11(2):114-8.
PMID:
3128945
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Fraschini G, Charnsangavej C, Carrasco CH,
Buzdar AU
, Jabboury KW, Hortobagyi GN. Percutaneous hepatic arterial infusion of cisplatin-vinblastine for refractory breast carcinoma metastatic to the liver. Am J Clin Oncol. 1988 Feb; 11(1):34-8.
PMID:
3277374
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
, Marcus C, Holmes F, Hug V, Hortobagyi G. Phase II evaluation of Ly156758 in metastatic breast cancer. Oncology. 1988; 45(5):344-5.
PMID:
3412740
.
Citations:
29
Fields:
Neo
Neoplasms
Translation:
Humans
Hortobagyi GN,
Buzdar AU
, Frye D, Hug V, Fraschini G, Ames FC, Montague E, Gutterman JU, Martin RG. Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer. A prospective, randomized trial. Cancer. 1987 Dec 01; 60(11):2596-604.
PMID:
3315173
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
CT
Clinical Trials
Hortobagyi GN, Frye D, Holmes FA, Hug V, Fraschini G,
Buzdar AU
. Phase II study of iproplatin in metastatic breast carcinoma. Cancer Treat Rep. 1987 Dec; 71(12):1193-6.
PMID:
3690529
.
Citations:
1
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
Fraschini G, Yap HY, Mann G,
Buzdar AU
,
Blumenschein GR
, Hortobagyi GN. Chemotherapy with mitoxantrone in combination with continuous infusion vinblastine for metastatic breast cancer. Cancer. 1987 Oct 15; 60(8):1724-8.
PMID:
3652000
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Moon TE, Jones SE, Bonadonna G, Valagussa P, Powles T,
Buzdar A
, Montague E. Development and use of a natural history data base of breast cancer studies. Am J Clin Oncol. 1987 Oct; 10(5):396-403.
PMID:
3310604
.
Citations:
9
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Jones SE, Moon TE, Bonadonna G, Valagussa P, Rivkin S,
Buzdar A
, Montague E, Powles T. Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base. Am J Clin Oncol. 1987 Oct; 10(5):387-95.
PMID:
3310603
.
Citations:
14
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Ro J,
Buzdar AU
, Esparza L, Hortobagyi GN. Phase II study of peplomycin in advanced breast carcinoma. Cancer Treat Rep. 1987 Jul-Aug; 71(7-8):777-8.
PMID:
2440571
.
Citations:
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
Holmes FA, Yap HY, Esparza L,
Buzdar AU
,
Blumenschein GR
, Hug V, Hortobagyi GN. Mitoxantrone, cyclophosphamide, and fluorouracil in metastatic breast cancer unresponsive to hormonal therapy. Cancer. 1987 Jun 15; 59(12):1992-9.
PMID:
3567861
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Zinser JW, Hortobagyi GN,
Buzdar AU
, Smith TL, Fraschini G. Clinical course of breast cancer patients with liver metastases. J Clin Oncol. 1987 May; 5(5):773-82.
PMID:
3106583
.
Citations:
36
Fields:
Neo
Neoplasms
Translation:
Humans
Ventura GJ,
Buzdar AU
, Kau S, Lichtiger B, Hortobagyi GN. Clinical trial of plasma perfusion over immobilized staphylococcal protein A in metastatic breast cancer. Cancer Treat Rep. 1987 Apr; 71(4):411-3.
PMID:
3548958
.
Citations:
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Hortobagyi GN, Bodey GP,
Buzdar AU
, Frye D, Legha SS, Malik R, Smith TL,
Blumenschein GR
, Yap HY, Rodriguez V. Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study. J Clin Oncol. 1987 Mar; 5(3):354-64.
PMID:
3819804
.
Citations:
17
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Hortobagyi GN,
Buzdar AU
, Bodey GP, Kau S, Rodriguez V, Legha SS, Yap HY,
Blumenschein GR
. High-dose induction chemotherapy of metastatic breast cancer in protected environment: a prospective randomized study. J Clin Oncol. 1987 Feb; 5(2):178-84.
PMID:
3543241
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Scheid V,
Buzdar AU
, Smith TL, Hortobagyi GN. Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy. Cancer. 1986 Dec 15; 58(12):2589-93.
PMID:
3779609
.
Citations:
28
Fields:
Neo
Neoplasms
Translation:
Humans
Larroquette CA, Hortobagyi GN,
Buzdar AU
, Holmes FA. Subclinical hepatic toxicity during combination chemotherapy for breast cancer. JAMA. 1986 Dec 05; 256(21):2988-90.
PMID:
3773217
.
Citations:
5
Fields:
Med
Medicine (General)
Translation:
Humans
Kramer A,
Buzdar AU
. Inflammatory breast carcinoma. Am J Clin Oncol. 1986 Dec; 9(6):541-3.
PMID:
3024479
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Hortobagyi GN,
Buzdar AU
. Progress in inflammatory breast cancer: cause for cautious optimism. J Clin Oncol. 1986 Dec; 4(12):1727-9.
PMID:
3783199
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Theriault RL, Hortobagyi GN,
Buzdar AU
, Levy HB, Hersh EM. Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer. Cancer Treat Rep. 1986 Nov; 70(11):1341-2.
PMID:
3768878
.
Citations:
2
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
Janjan NA, McNeese MD,
Buzdar AU
, Montague ED, Oswald MJ. Management of locoregional recurrent breast cancer. Cancer. 1986 Oct 01; 58(7):1552-6.
PMID:
3755648
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
Polyzos A,
Buzdar AU
. Complete remission with combination chemotherapy in metastatic breast carcinoma. Am J Clin Oncol. 1986 Aug; 9(4):361-3.
PMID:
3751975
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Herring MK,
Buzdar AU
, Smith TL, Hortobagyi GN,
Blumenschein GR
. Second neoplasms after adjuvant chemotherapy for operable breast cancer. Am J Clin Oncol. 1986 Jun; 9(3):269-75.
PMID:
3755282
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Hortobagyi GN. Adjuvant chemotherapy for breast cancer. JAMA. 1986 May 02; 255(17):2296.
PMID:
3959318
.
Citations:
Fields:
Med
Medicine (General)
Translation:
Humans
Feldman LD, Hortobagyi GN,
Buzdar AU
, Ames FC,
Blumenschein GR
. Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res. 1986 May; 46(5):2578-81.
PMID:
3697997
.
Citations:
65
Fields:
Neo
Neoplasms
Translation:
Humans
Casimir MT,
Buzdar AU
,
Blumenschein GR
, Hortobagyi GN, Bodey GP. Phase II study of AMSA and doxorubicin to treat metastatic breast cancer. Oncology. 1986; 43(4):205-7.
PMID:
3755230
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Holmes FA, Esparza L, Yap HY,
Buzdar AU
,
Blumenschein GR
, Hortobagyi GN. A comparative study of bisantrene given by two dose schedules in patients with metastatic breast cancer. Cancer Chemother Pharmacol. 1986; 18(2):157-61.
PMID:
3791560
.
Citations:
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
, Hortobagyi GN, Marcus CE, Smith TL, Martin R, Gehan EA. Results of adjuvant chemotherapy trials in breast cancer at M. D. Anderson Hospital and Tumor Institute. NCI Monogr. 1986; (1):81-5.
PMID:
3534594
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Hortobagyi GN,
Buzdar AU
, Marcus CE, Smith TL. Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute. NCI Monogr. 1986; (1):105-9.
PMID:
3534581
.
Citations:
19
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Lee RW,
Buzdar AU
,
Blumenschein GR
, Hortobagyi GN. Trioxifene mesylate in the treatment of advanced breast cancer. Cancer. 1986 Jan 01; 57(1):40-3.
PMID:
3940620
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Hortobagyi GN,
Buzdar AU
,
Blumenschein GR
, Yap HY, Hersh EM. Prediction of survival by degree of reactivity to BCG in patients with metastatic breast cancer. Dev Biol Stand. 1986; 58 ( Pt A):357-63.
PMID:
3596041
.
Citations:
Fields:
All
Allergy and Immunology
Tec
Technology
Translation:
Humans
Pasterz RB,
Buzdar AU
, Hortobagyi GN,
Blumenschein GR
. Mitomycin in metastatic breast cancer refractory to hormonal and combination chemotherapy. Cancer. 1985 Nov 15; 56(10):2381-4.
PMID:
4042070
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Mann GB, Hortobagyi GN,
Buzdar AU
, Yap HY, Valdivieso M. A comparative study of PALA, PALA plus 5-FU, and 5-FU in advanced breast cancer. Cancer. 1985 Sep 15; 56(6):1320-4.
PMID:
4027872
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Messeih AA, Lipton A, Santen RJ, Harvey HA, Boucher AE, Murray R, Ragaz J,
Buzdar AU
, Nagel GA, Henderson IC. Aminoglutethimide-induced hematologic toxicity: worldwide experience. Cancer Treat Rep. 1985 Sep; 69(9):1003-4.
PMID:
4028032
.
Citations:
4
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
Fraschini G, Yap HY, Hortobagyi GN,
Buzdar A
,
Blumenschein G
. Five-day continuous-infusion vinblastine in the treatment of breast cancer. Cancer. 1985 Jul 15; 56(2):225-9.
PMID:
4005794
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Marcus C, Smith TL,
Blumenschein GR
. Early and delayed clinical cardiotoxicity of doxorubicin. Cancer. 1985 Jun 15; 55(12):2761-5.
PMID:
3922612
.
Citations:
80
Fields:
Neo
Neoplasms
Translation:
Humans
Fastenberg NA, Martin RG,
Buzdar AU
, Hortobagyi GN, Montague ED,
Blumenschein GR
, Jessup JM. Management of inflammatory carcinoma of the breast. A combined modality approach. Am J Clin Oncol. 1985 Apr; 8(2):134-41.
PMID:
3841746
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Ross MB,
Buzdar AU
, Smith TL, Eckles N, Hortobagyi GN,
Blumenschein GR
, Freireich EJ, Gehan EA. Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Cancer. 1985 Jan 15; 55(2):341-6.
PMID:
3965092
.
Citations:
17
Fields:
Neo
Neoplasms
Translation:
Humans
Yau JC, Yap YY,
Buzdar AU
, Hortobagyi GN, Bodey GP,
Blumenschein GR
. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma. Cancer. 1985 Jan 15; 55(2):337-40.
PMID:
3880657
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Hortobagyi GN,
Buzdar AU
, Frye D, Yap HY, Hug V, Pinnamaneni K, Fraschini G, Halvorson HC,
Blumenschein GR
. Oral medroxyprogesterone acetate in the treatment of metastatic breast cancer. Breast Cancer Res Treat. 1985; 5(3):321-6.
PMID:
3161565
.
Citations:
11
Fields:
Neo
Neoplasms
Translation:
Humans
Buzdar AU
, Hortobagyi GN. Comment on 'Long-term tamoxifen adjuvant therapy in node positive breast cancer'. Breast Cancer Res Treat. 1985; 6(2):149-50.
PMID:
4052642
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Feldman LD,
Buzdar AU
,
Blumenschein GR
. High-dose 1-beta-D-arabinofuranosylcytosine in advanced breast cancer. Oncology. 1985; 42(5):273-4.
PMID:
4034143
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Hortobagyi GN,
Buzdar AU
, Ames FC,
Blumenschein GR
, Montague ED. Induction chemotherapy of breast cancer. Prog Clin Biol Res. 1985; 201:105-16.
PMID:
4095105
.
Citations:
Fields:
Bio
Biology
Med
Medicine (General)
Translation:
Humans
Buzdar AU
,
Blumenschein GR
. Breast cancer. Cancer Treat Rev. 1984 Dec; 11(4):315-9.
PMID:
6534512
.
Citations:
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
Kantarjian HM
, Hortobagyi GN, Smith TL,
Blumenschein GR
, Montague E,
Buzdar AU
, Martin RG. The management of locally advanced breast cancer: a combined modality approach. Eur J Cancer Clin Oncol. 1984 Nov; 20(11):1353-61.
PMID:
6548710
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
Moon TE, Jones SE, Bonadonna G, Powles TJ, Rivkin S,
Buzdar A
, Montague E. Using a database of protocol studies to evaluate therapy: a breast cancer example. Stat Med. 1984 Oct-Dec; 3(4):333-9.
PMID:
6528133
.
Citations:
Fields:
Sta
Statistics as Topic
Translation:
Humans
Holmes FA, Yap HY, Esparza L,
Buzdar AU
, Hortobagyi GN,
Blumenschein GR
. Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer. Semin Oncol. 1984 Sep; 11(3 Suppl 1):28-31.
PMID:
6385262
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Buzdar AU
. Adjuvant therapy of breast cancer. Tex Med. 1984 Sep; 80(9):37-8.
PMID:
6484865
.
Citations:
Fields:
Med
Medicine (General)
Translation:
Humans
Tannir N
, Yap HY, Hortobagyi GH, Hug V,
Buzdar AU
,
Blumenschein GR
. Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone. Cancer Treat Rep. 1984 Jul-Aug; 68(7-8):1039-41.
PMID:
6547638
.
Citations:
2
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
Aboud A,
Buzdar AU
, Yap HY, Hortobagyi GN,
Blumenschein GR
. Combination chemotherapy for metastatic breast cancer with fluorouracil, adriamycin, cyclophosphamide, and methotrexate. J Surg Oncol. 1984 Jul; 26(3):205-7.
PMID:
6610802
.
Citations:
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Smith L,
Buzdar AU
, Rusch V, Blocker SH, McKenna RJ. Post-mastectomy angiosarcoma: case report and review of the literature. Tex Med. 1984 Jul; 80(7):43-4.
PMID:
6379971
.
Citations:
Fields:
Med
Medicine (General)
Translation:
Humans
Finnerty NA,
Buzdar AU
,
Blumenschein GR
. Radiation-induced breast cancer. Arch Intern Med. 1984 Jun; 144(6):1217-9.
PMID:
6732380
.
Citations:
1
Fields:
Int
Internal Medicine
Translation:
Humans
Legha SS,
Ajani JA
,
Blumenschein GR
, Hortobagyi GN,
Buzdar AU
. Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio. Cancer. 1984 May 01; 53(9):1836-40.
PMID:
6231092
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Pinnamaneni K, Yap HY,
Buzdar AU
, Distefano A,
Blumenschein GR
. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone. Cancer. 1984 May 01; 53(9):1841-4.
PMID:
6546706
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Chawla SP,
Buzdar AU
, Hortobagyi GN,
Blumenschein GR
. Tumor-associated fever in bre